The interaction between ceramide-1-phosphate and Group IVA cytosolic phospholipase A2 and its role in wound healing by MacKnight, Patrick
Virginia Commonwealth University 
VCU Scholars Compass 
Theses and Dissertations Graduate School 
2018 
The interaction between ceramide-1-phosphate and Group IVA 
cytosolic phospholipase A2 and its role in wound healing 
Patrick MacKnight 
Virginia Commonwealth University 
Follow this and additional works at: https://scholarscompass.vcu.edu/etd 
 Part of the Biochemistry Commons, and the Molecular Biology Commons 
 
© The Author 
Downloaded from 
https://scholarscompass.vcu.edu/etd/5633 
This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It 
has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars 
Compass. For more information, please contact libcompass@vcu.edu. 
 
 
I 
 
 
 
 
 
 
 
 
 
 
 
 
 
©Henry Patrick Reece MacKnight           2018 
All Rights Reserved 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II 
 
 
 
The interaction between ceramide-1-phosphate and Group IVA cytosolic 
phospholipase A2 and its role in wound healing 
 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor 
of Philosophy at Virginia Commonwealth University   
 
 
 
By 
 
 
Henry Patrick Reece MacKnight,  
BS in Biological Sciences 
Texas A&M University of Commerce 2013 
 
Director: Charles Chalfant 
Department head  
Department of Cell Biology, Microbiology and Molecular Biology 
At the University of South Florida 
 
 
 
Virginia Commonwealth University 
Richmond, Virginia 
June 2018 
 
 
 
 
 
III 
 
Acknowledgements 
 
 As I come to the end of my PhD training and look back on everything I have 
experienced and learned, a phrase my mother always said comes to mind: “it takes a 
village to raise a child”. While getting a PhD and raising a child are clearly different, one 
thing is very similar, the amount of help and guidance it takes for both to be done properly. 
With that said, I have several people I would like to thank specifically for helping me get 
to this point in my life.  
 Firstly, Allen, Caleb, and Jordan, y’all have been pillars in my life and are the true 
definition of loyalty and friendship. I could never have asked for three better people too 
have shared the majority of my life. Thank you for your friendship and support during the 
past 10 years of my education and I look forward too many more years of friendship in 
the future.  
 To my graduate school friends thank all you, without y’all this day wouldn’t be 
possible. Your help in classes was instrumental in my surviving the first years of grad 
school, and your continued help with scientific conversation and ideas assisted in 
progressing my knowledge base further than I ever would have done on my own.  
 To the Dupree Lab, words cannot describe the feelings I have towards y’all. 
Savannah, thank you for your friendship, I am proud to say you are both my friend and 
colleague, you helped make grad school bearable in the worst of times and helped extend 
the good times. Dr. Dupree, thank you for all your guidance. This project would not have 
progressed like it did without your help and for that I can never thank you enough.  
 To the Ryan lab, y’all are my adopted lab family and I can truly say I am blessed 
to have had the opportunity to have y’all in my life. You took me in, gave me a place to 
 
 
 
IV 
 
work, and were always willing to discuss science and help me with my project. Thank y’all 
for everything and I wish the best for all of you in your future endeavors. 
 To the Chalfant lab, many members came through the lab during my tenure with 
y’all. Some stood out more than others for better and worse, but I want to say thank you 
specifically to a few individuals; Alexis, your guidance and friendship helped me get to 
this point. I know I drove you crazy, but I would like to believe that it all finally got through 
my thick head and I am now better for it. Margaret, you helped me any time I asked, even 
if it was a lame project (NPC1). You were always willing to discuss science and give 
guidance and for that I can’t thank you enough. Charles, I think you described my PhD 
experience best in that “it was the best of times and it was the worst of times” but thank 
you for your guidance and direction over the past 4 years. 
 To my committee, thank you for your guidance and advice throughout this whole 
process, it has made the PhD experience significantly easier knowing I had such a 
knowledgeable group of individuals available to help when needed. 
 To my family, I am going to keep this short because I just don’t have the space to 
say everything I want to, and words just don’t describe all of my feelings, but thank y’all 
for your never-ending support and encouragement. I hope that I have made y’all proud.  
 To Amelia, thank for everything. You are the love of my life and the reason I wake 
up in the morning. Without you I never would have gotten to this point. You make 
everything better and I could never have dreamed of having a wife half as incredible as 
you. I look forward to our future together and can’t wait to see what adventures are 
entailed. OK, honestly, I am crying, and my keyboard can’t take anymore tears, writing 
acknowledgments is way more emotional than I expected... 
 
 
 
V 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VI 
 
Table of Contents 
 
 
Page 
Copyright…………………………………………………………………………….…….……..I 
Title Page………………………………….………………………………………....………….II 
Acknowledgements………….…………...……………………………………...….…………III 
Table of contents………………………………………………………...................……...…VI 
List of Figures……..…………………..…………………………………………….…….......VII 
List of Tables…………………………………………………………………….....….........…IX 
List of Abbreviations……………..……...…………………………………………….....….…X 
Abstract………………………………..….……………………………………………..…...…XI 
Chapter 1 Introduction…..…..………………………………………………………………1 
Chapter 2 The C1P/cPLA2α interaction in acute wound healing…………………...…10 
Chapter 3 The C1P/cPLA2α in chronic wound healing…………………………………69 
Chapter 4 Discussion………………………………………………………………………83 
List of References……………………………...…………………………….........................86 
Vita……………………………………………...............……………………………...……..103 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VII 
 
LIST OF FIGURES 
 
Page 
1.1 Phases of Wound Healing……………………………………………………………...8 
1.2 Major biosynthetic pathways of eicosanoids……………….……………………….10 
2.1 Strategy and design of the novel cPLA2α KI mice……………….....……………...39 
2.2 Ablation of the C1P/cPLA2α interaction does not affect the in vivo wound 
 closure rate……………………………………………………………………………..41 
2.3 Histological evaluation of healed wounds from WT, cPLA2α KI, and cPLA2α KO 
 mice demonstrated a distinct phenotypical difference……………………………..43 
2.4 Healed wounds from WT, cPLA2α KI, and cPLA2α KO mice demonstrate 
 differences in collagen rod diameter and wound tensile strength……...…….…..45 
2.5 The loss of the C1P/cPLA2α interaction causes an increase in migration velocity 
 and collagen deposition in primary dermal fibroblasts……………...……………..47 
2.6 Genetic ablation of the C1P/cPLA2α interaction affects eicosanoid synthesis in 
 primary dermal fibroblasts and healed excisional wounds………...……...………49 
2.7 Viral recapitulation “rescues” the cPLA2α KI phenotype in cPLA2α KO pDFs..…51 
2.8 Exogenous addition of specific eicosanoids alters migration velocity in dermal 
 fibroblasts…………………………………………………..…………….………...…..53 
2.9 Small molecule inhibitors of cPLA2α and FLAP alter the migration velocity of 
 cPLA2α KI dermal fibroblasts…………………………………………………...…….55 
2.10 Primary dermal fibroblasts from cPLA2α KI mice demonstrate differential 
 localization of cPLA2α and FLAP……………………………………………............57 
 
 
 
VIII 
 
2.11 A schematic depiction of the current mechanistic hypothesis of cPLA2α regulation 
 in the presence and absence of ceramide-1-phosphate…………..….....………..59 
3.1 Classification of the four stages of pressure ulcers…………………………...…...73 
3.2 Genetic ablation of the C1P/cPLA2α interaction regulates wound closure in 
 pressure ulcers....................................................................................................75 
3.3 cPLA2α KI Neutrophils infiltrate wounded tissue at a greater rate than WT 
 Neutrophils...........................................................................................................77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IX 
 
LIST OF TABLES 
 
Page 
2.1 In vitro lipid profile from mechanically injured primary dermal fibroblasts from WT, 
 cPLA2α KI, and cPLA2α mice…………………………………………………………61 
2.2 In vivo lipid profile in acute excisional wounds from WT, cPLA2α KI, and cPLA2α 
 KO mice…………………………………………………………………………………63 
2.3 The altered lipid profile in primary dermal fibroblasts from the cPLA2α KI mouse 
 is cPLA2α-specific……………………………………………………………………...65 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
X 
 
LIST OF ABBREVIATIONS 
 
C1P  ceramide-1-phosphate 
cPLA2α group IVA cytosolic 
phospholipase A2  
WT  Wild Type 
cPLA2 KO cPLA2α knockout 
cPLA2 KI cPLA2α knock in 
IL-6  interleukin 6 
IL-4  interleukin 4 
IL-8  Interleukin 8 
TNF-α  Tumor necrosis factor alpha 
NF- Κb Nuclear Factor κ-light-chain 
Enhancer of Activated B cells  
ECM  Extracellular matrix 
Hex- Cer hexosylceramide 
SPK1  Sphingosine kinase 1 
TxA2  thromboxane A2 
COX  cyclooxygenase 
PGE2   prostaglandin E2 
6-KetoPGF1α 6-Keto- prostaglandin F1α 
LTA4  Leukotriene A4 
LTB4  Leukotriene B4 
LTD4  Leukotriene D4 
LTE4  Leukotriene E4 
5-HETE  5-Hydroxyeicosatetraenoic 
acid 
15-HETE 15-Hydroxyeicosatetraenoic 
acid 
LXA4  Lipoxins A4 
LXB4  Lipoxins B4 
AA   arachidonic acid 
PLA2  phospholipase A2 
CERK  ceramide kinase 
PTFE   Polytetrafluoroethylene 
pDFs  primary dermal fibroblast 
FLAP Five Lipoxygenase activating 
protein 
SMase D Sphingomyelinase D 
5-LO  Five Lipoxygenase 
LIGHT-/- TNFSF14/LIGHT 
kDa  kilodalton
 
 
 
 
XI 
 
 
 
 
Abstract 
The interaction between ceramide-1-phosphate and Group IVA cytosolic phospholipase 
A2 and its role in wound healing 
By 
Henry Patrick Reece MacKnight B.S. 
Dissertation Director: CHARLES E. CHALFANT 
Department head, department of Cell Biology, Microbiology and Molecular Biology 
at the University of South Florida 
 
The bioactive sphingolipid, ceramide-1-phosphate (C1P), directly binds and activates 
group IVA cytosolic phospholipase A2 (cPLA2α) to generate eicosanoids, which are key 
mediators of biological processes such as wound healing. In this study, we explored the 
role of the cPLA2α/C1P interaction in wound healing and repair using a novel genetic 
knockin model where this lipid:protein interaction was ablated (cPLA2α KI). In this model, 
a dramatic increase in dermal fibroblast infiltration into the wound environment was 
observed in contrast to both WT and cPLA2α knockout (KO) mice. Using a biomechanical 
approach, the enhanced infiltration of dermal fibroblasts into the wound correlated with a 
notable increase in wound tensile strength (>5-fold) in the cPLA2α KI compared to WT 
and KO mice. Furthermore, a significant increase in the orderly deposition of Type I 
collagen was observed, demonstrating that loss of the cPLA2α/C1P interaction enhanced 
wound maturation. These findings translated in vitro, as KI dermal fibroblasts showed a 
significantly increased rate of collagen deposition, as well as an increase in migration 
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velocity in comparison to both WT and KO fibroblasts. Additional mechanistic studies 
revealed an altered eicosanoid profile of reduced pro-inflammatory prostaglandins (e.g., 
PGE2) and increased levels of specific HETE species (e.g., 5-HETE) in the KI fibroblasts 
and wounds. Additional studies demonstrated a key role for 5-HETE in dermal fibroblast 
migration and collagen deposition. These studies are the first to demonstrate a key in vivo 
biological mechanism regulated by a structurally defined protein:lipid interaction.   
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Chapter 1 
Background 
 
1.1 Wound Healing 
 Wound healing is the process in which the body repairs damage to skin or tissue. 
For wound healing to occur properly, four distinct phases must happen in an orderly and 
timely fashion: hemostasis, inflammation, proliferation, and remodeling. While these 
phases are uniquely identifiable, there is significant overlap between them (Fig. 1.1).  
 The initial phase, hemostasis, begins immediately following injury and is generally 
classified as the body’s attempt to regulate the wound site by preventing blood loss. This 
occurs when platelets come in contact with collagen, which triggers a molecular cascade 
causing platelets to aggregate, forming a plug at the wound site designed to halt bleeding 
(Hawiger, 1987). This occurs in tandem with with production of signaling molecules such 
as eicosanoids released by ruptured blood vessels, causing nearby vessels to spasm and 
prevent further blood flow to the affected area. Though this period is short lived, 
approximately 10 minutes, it is critical for halting blood flow and recruiting inflammatory 
cells into the wound environment (RASCHE, 2001). As the clotting cascade is in motion, 
various cells begin releasing cytokines, growth factors, and eicosanoids, which both 
attract and direct cells during the wound process.(Gonzalez, Costa, Andrade, & Medrado, 
2016) The release of these signals is classically considered the period in which the 
inflammatory phase begins. The inflammatory phase can be divided into two steps, early 
and late inflammation.  
 Neutrophils are the predominant cell type that exists in the early inflammatory 
period. Their primary role is to prevent infection by killing invading bacteria entering the 
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body through the open wound. They achieve this goal by producing antimicrobial 
peptides, reactive oxygen species, and proteases. (Wilgus, Roy, & McDaniel, 2013) In so 
doing, there are often negative secondary effects, as the same tools used to fight bacteria 
also have negative effects on the host. Therefore, careful regulation of neutrophil activity 
in the wound environment is needed to insure productive continuation the of wound 
healing process. As the neutrophil response wanes, the wound transitions to the late 
inflammatory period in which we begin to see an increase in macrophage populations. 
Macrophages play two major roles in the wound environment: first, they cleanse the 
wound by phagocytizing bacteria, damaged tissue, and other immune cells, while also 
releasing proteases that help to clear damaged tissue.(Wilgus et al., 2013) Secondly, 
macrophages react to the often-hypoxic environment of the wound by producing factors 
that stimulate angiogenesis and re-epithelialization, and activate epithelial cells and 
fibroblasts to produce extracellular matrix proteins leading to granulation tissue.  
Significant overlap is seen between the end of the inflammatory phase and the 
beginning of the proliferative phase. The end of the inflammatory phases is signaled by a 
decrease in inflammatory mediators, neutrophils, and macrophages. This signals for the 
infiltration of the primary cell involved in the proliferative phase: fibroblasts. During the 
proliferative phase, the wound undergoes angiogenesis, collagen deposition, and 
epithelization. Angiogenesis, the process by which new vasculature is formed in the 
wound environment (Eming, Krieg, & Davidson, 2007), occurs through a multifaceted 
cascade, in which first macrophages release growth factors that stimulate and activate 
endothelial cells. These activated endothelial cells begin to separate from other cells as 
well as the surrounding tissue, by breaking down the junctions that keep them adhered 
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to their local environment. In conjunction with endothelial cell activation, cellular proteases 
in the environment also assist in freeing endothelial cells from the vascular basal lamina. 
Once free, the endothelial cells respond to chemotactic signals originating from the wound 
environment and migrate towards the wound. While migrating, these cells begin to lay 
down new vessels, which play a key role in providing the wound environment with the 
nutrients required for cells such as fibroblasts to proceed into the proliferation phase. As 
angiogenesis is occurring, the wound environment becomes less hypoxic. Increased 
oxygen tension is part of a trigger for fibroblast influx into the wound site. This is 
paramount to wound healing, since one of the main roles of fibroblasts is depositing type 
I collagen. Prior to this, the main structural components of the wound environment are 
type III collagen and fibronectin, which lack adequate tensile strength to permanently 
keep a wound closed when put under stressors from the outside.(Greenhalgh, 1998) 
Once collagen has been deposited and the granulation tissue has been formed, 
epithelization can occur. During epithelization, cells at the edges of the wound site begin 
to migrate inward and continue migrating and proliferating until both sides meet. The final 
portion of the proliferation phase involves contraction. This is considered one of the most 
important events in wound healing, due to the fact contraction is responsible for wound 
closure.(Chitturi et al., 2015; Tomasek, Gabbiani, Hinz, Chaponnier, & Brown, 2002) 
Contraction is largely regulated by a specialized fibroblast called myofibroblasts, which 
are denoted by expressing α-smooth muscle actin and resembling smooth muscle cells 
in their capacity for generating strong contractile forces.(R. A. F. (Richard A. F. . Clark & 
Henson, 1988) In normal healthy healed wounds, myofibroblasts subsequently undergo 
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apoptosis, preventing over contraction associated with significant scar tissue formation 
and weaker wound healing.(Li & Wang, 2011)  
The final phase of wound healing is the remodeling phase. As implied by the name, 
this phase involves the breakdown, generation, and reorganization of the wound 
environment, with the goal of generating a stronger wound that will have approximately 
80% of the tensile strength of the original uninjured tissue.(Morton & Phillips, 2016). 
During this phase type III collagen is degraded and converted to type I, and the excess 
vasculature previously needed for nourishing cells during the healing process begins to 
fade through apoptosis. The remodeling phase never truly ends in wound healing; the 
cells continue to rearrange and make the wound stronger. As previously stated, the 
wound healing process is a complicated and delicate process that requires many moving 
parts in order to be accomplished properly. In the next section we will go on to describe 
in greater detail several of the signaling molecules involved in the healing process. 
 
1.2  Signaling Molecules in wound healing 
 To this point it should be clear that wound healing is a complicated process 
requiring considerable cellular cross talk between the cells involved. This cross talk is 
accomplished by cells producing signaling molecules, such as cytokines, growth factors, 
and lipids, which can either act on the cell which produced them in an autocrine manner 
or be excreted and act on neighboring cells in a paracrine manner. In this section we will 
examine the members signaling molecules and how they interact to regulate the wound 
healing process. 
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 Cytokines are small proteins (5-25 kDa) that make up a large class of cellular 
signaling molecules produced by a myriad of cell types and have various functions in 
cellular systems. Studies done by numerous investigators have continually demonstrated 
the important role of cytokines in wound healing. To highlight this, we will discuss several 
cytokines and the important work that has demonstrated their role in wound healing.  We 
begin with interleukin 6 (IL-6), a well described cytokine shown to play a significant role 
in inflammation. The importance of IL-6-regulated inflammation in wound healing was 
demonstrated when Gallucci and colleagues examined the wound healing process in IL-
6-deficient (KO) mice. Wounded IL-6 KO mice displayed a delayed wound healing 
phenotype associated with delays in macrophage infiltration, fibrin clearance, and 
vascularization (Lin, Kondo, Ishida, Takayasu, & Mukaida, 2003; McFarland-Mancini et 
al., 2010) These data demonstrated that timely initiation of inflammation is essential for 
proper wound closure. 
Another important player in the wound healing process is interleukin 4 (IL-4). IL-4 is 
a 20kDa cytokine mainly produced by T-lymphocytes and mast cells that has been shown 
to have distinct biological effects on multiple cell types. Of interest is work done by Gillery 
and colleagues implicating IL-4 as a molecule that regulates extracellular matrix 
deposition from fibroblasts.(Gillery et al., 1992) This study demonstrated that exogenous 
addition of recombinant IL-4 on fibroblast monolayers directly regulated collagen gene 
expression, suggesting IL-4 is an essential for proper wound closure. 
 Interleukin 8 (IL-8) is another cytokine shown to play a large role in the wound 
healing process by regulating keratinocyte proliferation as well as acting as a chemotactic 
reagent for neutrophil influx.(Rennekampff et al., 2000) 
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 Tumor necrosis factor alpha (TNF-α) is a cytokine that for a significant time was 
shown to act as both a positive and negative regulator in the wound healing process 
(Rapala, 1996). As of recently, new research using TNF-α neutralizing antibodies 
demonstrated a reduction of leukocyte recruitment and NFB activation, as well as an 
increase macrophages. (Ashcroft et al., 2012) In contrast, extracellular matrix (ECM) 
synthesis was upregulated during treatment with TNF-α neutralizing antibodies. This work 
shows that though TNF-α plays an important role in inflammation, unregulated expression 
could lead to a chronic non-healing wound. 
 In addition to cytokines, various lipid classes such as ceramides and eicosanoids 
have been shown to play an integral role in wound healing. Early examining the role of 
ceramides in wound healing demonstrated an important role, in which hexosylceramide 
(Hex-Cer) was shown to improve neovascularization in a rabbit wound chamber 
model.(Niinikoski, Laato, Tschannen, & Fraefel, 1986) Additional work also demonstrated 
an important role for Sphingosine kinase 1 (SPK1), a key enzyme in sphingolipid 
metabolism, in wound healing. By using an inducible diabetic rat model and 
overexpressing SPK1 in the wound environment for 21 days, Yu and colleagues showed 
that increased levels of SPK1 significantly increased wound closure rate as compared to 
untreated control mice.(Yu, Yuan, Xu, Zhang, & Duan, 2014) 
Eicosanoids make up one the most important classes of lipids in the wound healing 
process and are comprised of subclasses, such as prostaglandins, prostacyclins, 
thromboxanes, leukotrienes and lipoxins. Eicosanoid synthesis begins with the initial rate-
limiting step of arachidonic acid (AA) formation, via the activity of phospholipase A2 (PLA2) 
In many cases, inflammatory agonists such as cytokines induce the activation and 
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translocation of cytosolic phospholipase A2 (cPLA2a) in either a Ca+2-dependent or –
independent manner, at which point AA is acted upon by various enzymes giving rise to 
a myriad of eicosanoids. (Fig. 1.2) When assessing the role eicosanoids play in the 
healing process, one of the initial mediators is thromboxane A2 (TxA2), which promotes 
hemostasis through signaling for vasoconstriction, platelet aggregation, and monocyte 
infiltration.(Lefer, 1985) Early in the healing process the cyclooxygenase (COX) enzymes 
are induced, which regulate the production of specific prostaglandins and prostacyclins, 
such as prostaglandin E2 (PGE2) and 6-Keto- prostaglandin F1α (6-KetoPGF1α), both of 
which play roles in vasodilation and platelet disaggregation.(Sandulache, Parekh, Li-
Korotky, Dohar, & Hebda, 2006) As the hemostasis phase begins to end, the 
inflammatory phase begins. During this phase we see significant increases in 
proinflammatory eicosanoids such as Leukotriene A4 (LTA4), Leukotriene B4 (LTB4), and 
5-Hydroxyeicosatetraenoic acid (5-HETE), which are associated with immune cell 
infiltration.(Borgeat, Hamberg, & Samuelsson, 1976; Brady, Persson, Ballermann, 
Brenner, & Serhan, 1990) Towards the end of the inflammatory phase, production of 
Lipoxins A4 and B4 (LXA4) (LXB4)(Cianci et al., 2016) increases, signaling the exodus of 
immune cells and the infiltration of cells responsible for ECM deposition and wound 
closure.  
What is abundantly clear at this point is wound healing is an intricate and delicate 
dance in which a myriad of interactions occur between various signaling molecules, 
resulting in complex regulation processes that attempt to insure rapid, orderly, and proper 
wound closure. Further research into understanding these interactions is necessary to 
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advance our ability to treat and improve the quality of life of injured individuals, which we 
will discuss in future chapters of this dissertation. 
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Figure 1.1 The 4 Phases of Wound Healing. Wound healing is divided into four distinct 
but overlapping phases: Hemostasis, Inflammation, Proliferation, and Remolding. During 
hemostasis blood clot formation and vasoconstriction occur in order to stop bleeding and 
collect local immune cells. The inflammatory phase is indicated by an influx of immune 
cells such as neutrophils and macrophages These cells play an essential role in cleaning 
the wound and prepping it for closure. Once macrophages have begun to exit the wound 
environment the proliferative phase can be begin, in which fibroblasts invade and begin 
the process of laying down new connective tissue and micro blood vessels (granulation 
tissue) as well as collagen deposition. Finally, in the remodeling phase the wound is 
allowed to mature by degrading the type III collagen that was laid down in the early phases 
of healing. Along with degradation, collagen fibers are rearranged and cross-linked. If 
healing continues in a timely manner, eventually the healed wound will reach about 80% 
of its original strength.  
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Figure 1.2 Major biosynthetic pathways of eicosanoids. Schematic of major 
eicosanoid pathways containing lipoxygenase, cyclooxygenase, and P450 enzymes. 
Abbreviations: Resolvin D1-6 (RvD1-6), Resolvin E1-2 (RvE1-2), Protectin D1 (PD1), 
Maresin 1-2 (MaR1-2), Leukotrienes A4,B4,A5,B5 (LTA4,LTA5,LTB4,LTB5), Prostaglandin 
H3,I3,E3,G2,H2,E2,D2,F2,I2 (PGH3, PGI3, PGE3, PGG2, PGH2, PGE2, PGD2, PGF2 
PGI2,), Thromboxanes A2,B2 (TxA2TxB2) 
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Chapter 2 
The C1P/cPLA2α interaction in acute wounds 
2.1 INTRODUCTION 
Wound healing is a dynamic process involving four main phases during which a 
myriad of cells and signaling molecules interact to complete the healing process in a 
timely and orderly fashion. The four distinct, yet overlapping phases, that make up the 
healing process are hemostasis, inflammation, proliferation, and remodeling.(R. A. F. 
Clark, 1988; Enoch & Price, 2004) During hemostasis, clotting factors work in tandem, 
constricting blood vessels to decrease bleeding.(Versteeg, Heemskerk, Levi, & Reitsma, 
2013)  As the hemostasis phase ends, the wound transitions into the inflammatory phase, 
where several hallmark events occur: vasodilation, increased vascular permeability, and 
lastly neutrophil and macrophage infiltration into the wound site.(Diegelmann, Evans, & 
others, 2004; M.-H. Kim et al., 2008; Koh & DiPietro, 2011)  After the wound has been 
cleared of any foreign debris and is properly prepped by the cells involved in inflammation, 
the proliferation phase begins, at which point fibroblasts and keratinocytes migrate into 
the wound and initiate wound closure. Additionally, during this phase, angiogenesis 
occurs.(Broughton, Janis, & Attinger, 2006; Sivamani, 2014a)  The final phase of the 
healing process is remodeling, which involves formation of new epithelial layers as well 
as increased deposition and crosslinking of collagen. Once completed, the healed wound 
has approximately 80% of the original tissue strength.(Ireton, Unger, & Rohrich, 2013) 
This study focuses on the role of eicosanoids in wound healing. These bioactive 
lipids have emerged as key players involved in the normal wound healing process. As 
such, a manifestation of impaired wound healing is the development of an imbalance 
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between pro- and anti-inflammatory lipids such as the arachidonic acid (AA)-derived 
eicosanoids lipid mediators.(Dhall et al., 2015b) Specifically, PGE2 has been implicated 
in the regulation of cell migration and meandering during the healing process of acute 
wounds.(White et al., 2005a) Leukotrienes are another class of eicosanoid that play a 
major role in the wound healing process. For example, leukotriene B4 (LTB4) recruits 
neutrophils to areas containing damaged tissue (Luo et al., 2017), which as previously 
stated, is one of the initial phases of the wound healing process.  
In addition to the healing of acute wounds, bioactive lipids contribute to the 
impaired healing of chronic wounds. For example, the excess inflammation associated 
with impaired healing of pressure ulcers correlates with high levels of pro-inflammatory 
eicosanoids (e.g., LTD4, LTE4, PGE2).(Dhall et al., 2015b) Blockade of COX-2-derived 
eicosanoids (e.g., PGE2) reduces inflammation and improves the healing of pressure 
ulcers in mice.(Romana-Souza, Santos, Bandeira, & Monte-Alto-Costa, 2016) Localized 
excess of PGE2 has also been linked to delayed wound healing and inhibition of fibroblast 
function.(White et al., 2005b) Furthermore, PGE1, an anti-inflammatory prostaglandin 
acting in opposition to the pro-inflammatory PGE2, is approved to treat human 
wounds.(Co., 2010)  Additional reports indicate that the bioactive fraction in platelet-rich 
plasma for wound therapy is a lipid component and that nutritional formulations containing 
pro-resolution lipids decrease the progression of pressure ulcers.(Lauren Alexis Hoeferlin 
et al., 2015; Theilla et al., 2012) Together, these findings support key and distinct roles 
for eicosanoids in the wound healing process and in its dysregulation/“stalling”. Yet, 
therapeutic treatments to modulate these pathways in the clinical setting with the goal of 
improving healing outcomes remain limited.  
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Eicosanoid synthesis begins with the initial rate-limiting step, formation of AA via 
the activity of a phospholipase A2 (PLA2). (J. D. Clark, Schievella, Nalefski, & Lin, 1995; 
Leslie, 1997; Pettus et al., 2003; Stephenson, Hoeferlin, & Chalfant, 2017) One of the 
major PLA2s involved in this initial step is cPLA2α. Previously, our laboratory 
demonstrated that the translocation of cPLA2α to intracellular membranes, as well as AA 
release and production of downstream eicosanoids, were dependent upon C1P 
interacting with the C2 domain of this enzyme at residue, R59, and possibly R57 and K58.(L. 
Alexis Hoeferlin, Wijesinghe, & Chalfant, 2013; Lamour et al., 2009; Stahelin, 
Subramanian, Vora, Cho, & Chalfant, 2007a; Ward et al., 2013) Later studies suggested 
that both R61 and H62 were also key residues for the C1P interaction and induction of 
cPLA2α translocation to membranes.(Stahelin, Subramanian, Vora, Cho, & Chalfant, 
2007b)   More recently, our laboratory reported that C1P derived from ceramide kinase 
(CERK) negatively regulates the migration of murine embryonic fibroblasts. Furthermore, 
C1P levels were elevated in the inflammatory phase, but decreased during the 
proliferation/remodeling stage in human wound healing using a novel PTFE-insertion 
model.(Wijesinghe et al., 2014) 
Based on the preceding findings, we hypothesized that the C1P/cPLA2α interaction 
regulates wound repair and regeneration. In this study, we tested this premise using a 
novel genetic mouse model, and found that this lipid: protein interaction negatively 
regulates the later phases of wound healing. To our knowledge, this is the first report of 
a defined lipid:protein interaction regulating a biological phenotype in an in vivo 
mammalian model. Furthermore, our data suggest a new mechanistic paradigm for 
cPLA2α in shifting cell function depending on the association of the enzyme with specific 
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lipid mediators. Overall, the data not only reinforce the integral role that eicosanoids play 
in the wound healing process by demonstrating a novel role for 5-HETE, but also 
demonstrate the importance of protein:lipid interactions, such as the C1P/cPLA2α 
interaction. 
 
2.2 RESULTS 
 
Ablation of the C1P/cPLA2α interaction does not affect the closure rate of acute 
wounds. 
 In order to study the role of the C1P/cPLA2α interaction in vivo, a novel genetic 
mouse was designed and created with an ablated C1P/cPLA2α interaction (cPLA2α KI 
mouse) (Fig.2.1A).  This mouse model was designed using a construct with an inserted 
cassette containing puromycin resistance, a premature stop codon flanked by loxP sites, 
and three mutated amino acids (R57A, K58A, R59A) in the endogenous cPLA2α locus (2.1A, 
red stars exon 4). The design enabled generation of a cPLA2α knockout mouse (e.g., 
cPLA2α-KO) that can be converted to the cPLA2α-KI genotype by Cre-mediated 
recombination. cPLA2α mRNA levels and genotyping were confirmed via RT-qPCR and 
end-point PCR, respectively (Fig.2.1B and C). Of note, the cPLA2α-KO mouse was further 
confirmed by demonstrating the reported breeding phenotype for this genetic ablation 
model (i.e., dramatic reduction of litters due to spontaneous abortion) (data not shown). 
Using our novel genetic models, the cPLA2α wild-type (cPLA2α-WT), cPLA2α-KI, and 
cPLA2α-KO mice were examined for acute wound healing using a punch-biopsy model 
as reported by Wang and co-workers.(Wang, Ge, Tredget, & Wu, 2013a) Specifically, 
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mice were injured using 6 mm biopsy punches on the shaved dorsum, and wounds were 
stinted open as described.(Wang, Ge, Tredget, & Wu, 2013b) The wound closure rate 
was observed over the course of 14 days. No significant differences were observed in the 
closure rate between the cPLA2α-WT, cPLA2α-KI, and cPLA2α-KO mice (Fig. 2.2). These 
data show that both cPLA2α and the C1P/cPLA2α interaction do not play a role in the 
closure rate of acute wounds in mice.  
 
Altered wound healing and maturation occurs in cPLA2α KI mice. 
The lack of a significant effect on the rate of in vivo wound closure was not 
unexpected as the wound closure rate for acute wounds in mice is more dependent on 
contraction-based mechanisms in contrast to humans.(GRILLO, WATTS, & GROSS, 
1958; Kennedy & Cliff, 1979; McGrath & Simon, 1983) We next examined the wounds for 
other healing processes that are similar in mice and humans, such as chemotactic 
responses, fibroblast migration, and wound maturation/remodeling.(Galiano, Michaels, 
Dobryansky, Levine, & Gurtner, 2004; Wong, Sorkin, Glotzbach, Longaker, & Gurtner, 
2011b) Furthermore, since eicosanoids play a pivotal role in the chemotactic response of 
cells both in vivo and in vitro,(Sivamani, 2014a; Wijesinghe et al., 2014) histological 
evaluations of healed wounds were performed on the cPLA2α-WT, cPLA2α-KI, and 
cPLA2α-KO mice. Masson’s trichrome stain of healed wounds (10 days) demonstrated a 
dramatic increase in cell infiltration into the healed wound of cPLA2α-KI mice in stark 
contrast to both cPLA2α WT and KO mice (Fig. 2.3A).    
By day 10, the wound is normally expected to be undergoing both the proliferation 
and remodeling phases of wound healing, which involves infiltration and proliferation of 
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dermal fibroblasts.(R. A. F. Clark, 1988; Midwood, Williams, & Schwarzbauer, 2004) In 
order to determine the cell type infiltrating into the healed wounds of the cPLA2α-KI 
mouse, tissue sections were analyzed for a standard immunohistochemical fibroblast 
marker, Heat shock protein 47. The tissue sections show that the healed wounds of the 
cPLA2α-KI mice contained increased levels of dermal fibroblasts (Fig. 2.3B and E). These 
data indicate that the C1P/cPLA2α interaction acts as a negative regulator of fibroblast 
migration into the wound environment during the healing process of acute wounds. 
To determine whether the enhanced numbers of dermal fibroblasts observed in 
the wounds of the cPLA2α-KI mice affected wound repair and maturation negatively or 
positively, picrosirius red staining was used to examine collagen deposition.(Schmidt et 
al., 2016) A dramatic increase in the ratio of type I to type III collagen in the healed wounds 
of cPLA2α-KI mice was observed (Fig. 2.3F). Interestingly, it has been reported that an 
increase in type I collagen indicates more advanced progression through the wound 
healing process.(Gonzalez et al., 2016; Lorenz & Longaker, 2008) Since type I collagen 
deposition correlates with wound maturation, our data demonstrate that the loss of 
C1P/cPLA2α interaction positively impacts acute wound healing process. 
 
Ablation of the C1P/cPLA2α interaction in mice is associated with enhanced wound 
remodeling and tensile strength.  
 To determine whether the loss of the C1P/cPLA2α interaction affected the orderly 
deposition and cross-linking of collagen rods, electron microscopy was utilized to examine 
collagen rod diameters in wound tissue, which has been associated with an increase in 
wound tensile strength.  A profound difference in the profile of the collagen rods was 
 19 
 
observed in cPLA2α KI mice compared to cPLA2α-WT and cPLA2α-KO mice (Fig. 2.4A 
and B). Specifically, the rod diameter of collagen was dramatically reduced in wounds 
from the cPLA2α-KI mice to a range of 10 to 19 nm in contrast to a diameter range of 30 
to 49 nm in both cPLA2α-KO and cPLA2α-WT wounds. Since wound strength has been 
shown to be associated with both type I collagen deposition as well as smaller collagen 
rod diameter in healed wounds, (Khorasani et al., 2011; Pickett, Burgess, Livermore, 
Tzikas, & Vossoughi, 1996; Xue & Jackson, 2015) we next examined wound tensile 
strength. Importantly, healed wounds of cPLA2α-KI mice exhibited significantly increased 
tensile strength as compared to wounds from WT and cPLA2α-KO mice (Fig. 2.4C.).  
Taken together, these data indicate that the genetic ablation of the C1P/cPLA2α 
interaction enhances wound maturation, remodeling, and repair for acute wounds in mice.  
 
Ablation of the C1P/cPLA2α interaction enhances the migration of primary dermal 
fibroblasts.  
 A large body of research has demonstrated that eicosanoids play a pivotal role in 
the orderly migration and meandering of fibroblasts.(Sivamani, 2014b; Wijesinghe et al., 
2014) Because cPLA2α-KI mice showed an enhanced wound maturation phenotype that 
was linked to greater fibroblast infiltration and collagen Type I deposition, we next 
determined whether this phenotype could be recapitulated in vitro in primary dermal 
fibroblast (pDFs). More specifically, we determined whether this cell type was directly 
involved in mediating the observed in vivo phenotypes. As shown in Figure 5A-C, no 
phenotypic differences in cell appearance and actin fiber distribution were observed for 
pDFs from the three genotypes.  However, significantly increased migration velocity was 
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observed for pDFs from the cPLA2α-KI mouse compared to pDFs from cPLA2α-WT and 
cPLA2α-KO mice (Fig. 2.5D-F). Cell meandering was also assessed, but no significant 
difference was seen between the genotypes (data not shown). Lastly, collagen deposition 
in pDF cells from cPLA2α-KI mice was significantly increased compared to pDFs from 
cPLA2α-KO and cPLA2α-WT mice (Fig. 2.5G). The data indicate that C1P/cPLA2α 
interaction is a negative regulator of pDF migration speed and collagen deposition but 
does not play a significant role in the migration polarity of pDFs. 
 
Ablation of the C1P/cPLA2α interaction alters the lipid profile in primary dermal 
fibroblasts.  
 Because of the known involvement of eicosanoids in regulating fibroblast 
migration,11-13 a broad lipidomics screen was performed utilizing UPLC ESI-MS/MS. 
Significant decreases in several AA-derived eicosanoids (e.g., PGE2) were observed in 
pDFs with the ablated C1P/cPLA2α interaction. Similar findings were observed, 
irrespective of mechanical trauma, for cPLA2α-KO cells compared to WT pDFs (Fig. 2.6A, 
B, Table 1). Interestingly, however, significant increases in the levels of several HETES 
(e.g. 5-HETE and 15-HETE) were observed in cPLA2α-KI pDFs compared to both WT 
and cPLA2α-KO pDFs (Fig. 2.6B and C, Table 2.1). These pDF data correlated with lipid 
profiles from in vivo wounds, as 5-HETE was increased and PGE2 decreased in cPLA2α-
KI mice after 10 days (Fig. 2.6D and E, Table 2.2). The data support the novel hypothesis 
that the C1P/cPLA2α interaction is functioning as both a positive and negative regulator 
of specific eicosanoid biosynthetic pathways.  
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To confirm that the altered eicosanoid profile is due to the mutant cPLA2α (mutant-
cPLA2α [R57A, K58A, R59A]) and not due to off-target activation of a separate PLA2 
system, pDFs were treated with a selective cPLA2α inhibitor, pyrrophenone. The 
enhanced HETE levels (e.g., 5-HETE) observed in cPLA2α-KI pDFs were blocked by 
pyrrophenone without significantly affecting HETE levels in the WT and KO pDFs (Table 
2.3).  
Unexpectedly, mutant cPLA2α protein expression in the cPLA2α-KI pDFs was 
found to be significantly reduced as compared to WT pDFs, whereas mRNA expression 
was reduced only 15% (Fig. 2.1B and 2.7A). To demonstrate that the altered eicosanoid 
profile was due to the ablation of the C1P/cPLA2α interaction and not reduced protein 
expression, both WT and mut-cPLA2α (R57A, K58A, R59A) were re-expressed in KO pDFs 
to the same expression level (Fig. 2.7B). Mut-cPLA2α expression in KO pDFs induced the 
same eicosanoid profile as the cPLA2α KI pDFs, with even further enhancement of 5-
HETE production (Fig. 2.7C and D). Notably, expression of the WT cPLA2α in KO pDFs 
“rescued” the eicosanoid profile to that of WT pDFs (Fig. 2.7C and D). Mut-cPLA2α 
expression also yielded the migration phenotype seen in cPLA2α-KI pDFs (Fig. 2.7E). 
These data confirm that the C1P/cPLA2α interaction is not only a positive regulator of a 
large number of inflammatory eicosanoids, but also acts as a negative regulator for the 
production of 5-lipoxygenase-derived lipid mediators such as 5-HETE. Our data strongly 
suggest that ablation of the C1P/cPLA2α interaction leads to the induction of a “gain of 
function” phenotype for the enzyme that drives 5-HETE production in pDFs.  
 
5-HETE drives the cPLA2α KI migration phenotype. 
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 To determine whether the production of specific HETE species was responsible 
for the enhanced migration of the cPLA2α KI pDFs, we relied on exogenous addition of 
specific eicosanoids and of small molecule inhibitors of pertinent biosynthetic enzymes.  
The addition of 5-HETE to WT pDFs, but not 12-, 15-, or 20-HETE recapitulated the 
increased migration velocity phenotype of cPLA2α-KI pDFs (Fig. 2.8A and data not 
shown). Of note, 5-HETE was the only HETE species to recapitulate the cPLA2α-KI 
phenotype in WT pDFs using levels moderately above the concentrations produced by 
the cPLA2α-KI pDFs (Fig. 2.8A). We surmised that the production of higher PGE2 levels 
in WT pDFs as compared to cPLA2α-KO and cPLA2α-KI pDFs necessitates higher levels 
of 5-HETE to increase the migration velocity, because PGE2 is a known inhibitor of 
fibroblast migration (Fig. 2.8A). To test the validity of this idea, pDFs from cPLA2α-KO 
mice, which produce almost no PGE2, were treated with various concentrations of 5-
HETE. In contrast to WT pDFs, extremely low levels of 5-HETE were able to enhance the 
migration velocity of these pDFs to the same extent as observed for cPLA2α-KI pDFs (Fig. 
2.8B). These data show that the loss of the C1P/cPLA2α interaction produces the optimal 
eicosanoid pattern for enhanced pDF migration by providing reduced levels of migration-
suppressing eicosanoids (i.e., PGE2) while increasing the levels of the pro-migratory lipid 
mediator, 5-HETE.   
In control studies, pyrrophenone was again used to treat pDFs to show that the 
effects on migration velocity are due to the mutant cPLA2α (mutant-cPLA2α R57A, K58A, 
R59A]) and not off-target activation of a separate PLA2 system. The enhanced migration 
velocity of cPLA2α-KI pDFs was blocked by addition of pyrrophenone, with no significant 
effects observed for the WT and KO pDFs (Fig. 2.9A). These data support the finding that 
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the enhanced migration velocity observed in the cPLA2α-KI pDFs is due to a “gain of 
function” or “shift in function” exerted by the mutant enzyme.  To further reinforce the role 
of 5-HETE in regulating pDF migration, MK886, an inhibitor of Five Lipoxygenase 
activating protein (FLAP), was used to block 5-LO production of 5-HETE. MK886 
treatment of both WT and cPLA2α-KO pDFs had no significant effect on pDF migration 
velocity as compared to untreated samples (Fig. 2.9B). In contrast, MK886 significantly 
decreased the migration velocity of cPLA2α-KI pDFs to that of WT pDFs (Fig. 2.9B), in 
contrast to sham-treated cPLA2α-KI DFs (not shown). Lastly, cPLA2α-KI pDFs were 
treated with combinations of pyrrophenone, MK886, and 5-HETE. Exogenous addition of 
5-HETE “rescued” the cPLA2α-KI phenotype in both the pyrrophenone- and MK886-
treated cPLA2α-KI pDFs (Fig. 2.9C).  Together, these data support the conclusion that 
ablation of the C1P/cPLA2α interaction induces production of 5-HETE, at the expense of 
PGE2 production, with the net effect of enhancing pDF migration. 
 
cPLA2α KI dermal fibroblasts display altered colocalization of the 5-lipoxygenase 
activating protein (FLAP) and cPLA2α 
  Previous work has demonstrated that localization and expression of synthetic 
enzymes play a key role in the levels of both HETE and leukotriene production.(Rådmark, 
Werz, Steinhilber, & Samuelsson, 2015) Thus, we explored the mechanism used by 
mutant-cPLA2α enzyme to drive 5-HETE production at the expense of other inflammatory 
eicosanoids. Immunocytochemistry coupled to confocal microscopy revealed both FLAP 
and cPLA2α to be cytosolically localized in cPLA2α-KI pDFs, in stark contrast to the 
nuclear localization of FLAP and Golgi/peri-nuclear localization of cPLA2α in WT pDFs 
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(Fig. 2.10A and B).  Moreover, mut-cPLA2α and FLAP were co-localized in cPLA2α-KI 
pDFs, again, in stark contrast to their localization in WT pDFs.  Also, FLAP protein 
expression was significantly decreased in the cPLA2α-KI pDFs as compared to WT pDFs 
(Fig. 2.10D and E). These data demonstrate that the increased 5-HETE production by the 
cPLA2α KI mutant arises not only from FLAP differential expression, but also from 
cytoplasmic co-localization of FLAP with mut-cPLA2α.  
 
DISCUSSION 
 In order to explore whether the C1P/cPLA2α interaction plays a significant role in 
the wound healing process; our lab designed and utilized a novel genetic model where 
the C1P interaction site in cPLA2α was ablated. This mouse model demonstrated: (1) 
increased dermal fibroblast infiltration into the wound environment; and (2) enhanced 
progression through the stages of wound healing as measured by a significant increase 
in Type I collagen deposition, reduced collagen rod diameter, and dramatically enhanced 
wound strength. These novel phenotypes were linked to an altered eicosanoid profile 
observed in pDFs and the wounds themselves. Our mechanistic studies showed that the 
loss of inflammatory prostaglandins with a concomitant increase in 5-HETE was key to 
driving the observed fibroblast phenotypes. Overall, these data support a role for the 
C1P/cPLA2α interaction in the inflammatory stage of wound healing, thus serving as a 
negative regulator of the proliferation and remodeling stages of the healing process. 
Therefore, blocking C1P production or the interaction of this lipid with cPLA2α could be 
beneficial in “compressing” the inflammatory phase and inducing the 
proliferation/remodeling phases earlier. Indeed, our laboratory reported that C1P levels 
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were increased concomitantly with the inflammatory stage of wound healing in human 
subjects, followed by a significant decrease during the proliferation and remodeling 
stages.(Contaifer et al., 2017) Thus, exogenous 5-HETE or an inhibitor of the 
cPLA2α/C1P interaction may provide significant healing improvement. This may also be 
adaptable to chronic wounds such as pressure ulcers, which are “stalled” in the 
inflammatory stage with a failure to resolve. Indeed, the continued association of cPLA2α 
with membrane C1P may be a key cellular mechanism linked to the “stalling” of the wound 
healing process in pressure ulcers. This hypothesis is supported by the knowledge that 
cyclic C1P generation by sphingomyelinase D from the venom of the Brown Recluse 
spider leads to ulcerated wounds in humans. (DeLozier, Reaves, King, & Rees, 1988; 
Hadanny, Fishlev, Bechor, Meir, & Efrati, 2016) 
 An unexpected finding from this study is the “gain of function” observed for the 
mutant cPLA2α. From past research reported by our laboratory, the interaction of 
ceramide-1-phosphate with cPLA2α was hypothesized to be required for the function of 
the enzyme. Whereas we confirmed our original findings, demonstrating that the loss of 
the C1P/cPLA2α interaction suppresses some prostaglandins such as PGE2, it was 
completely unexpected to both observe an increase in HETEs as well as novel 
phenotypes for the cPLA2α KI mouse in comparison to the cPLA2α KO mouse. As a 
specific cPLA2α inhibitor blocks both the increased HETEs and migration of pDF from 
cPLA2α KI mice, the differential effects from the cPLA2α KO are likely due to a “gain of 
function” of the mutant enzyme versus a developmental adaptation inducing the utilization 
of a separate PLA2 class. This was further confirmed by expressing mutant cPLA2α in 
cPLA2α KO cells, which induced the same novel lipid profile and migration phenotype. 
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These observations support a model in which the mutant-cPLA2α shifts its cellular 
location, due to the inability to bind C1P in the basal and induced conditions, and now co-
localizes with biosynthetic enzymes associated with 5-HETE production (Fig. 2.11A and 
B). These data demonstrate a potential mechanism in which loss of the cPLA2α-C1P 
interaction induces an altered enzyme localization that, through unknown means, recruits 
FLAP and inhibits FLAP nuclear localization to drive 5-HETE production.  
 In regard to our proposed mechanism, the question remains as to how loss of the 
C1P/cPLA2α interaction “shifts” the enzyme to a previously uncharacterized function 
inhibited in the presence of C1P in specific cellular membranes. Indeed, the enzyme has 
multiple regulatory mechanisms as well as calcium-dependent and -independent 
functions. As C1P usually requires the presence of calcium to interact with the enzyme, 
loss of the interaction may “shift” cPLA2α to a more calcium-independent role usually akin 
to PIP2 regulation of the enzyme. Our previous work with both PIP2 and C1P activation of 
cPLA2α suggests this possibility, as the presence of C1P inhibits the calcium-independent 
activation of cPLA2α by PIP2 in vitro, and C1P has higher affinity for the enzyme than 
PIP2.(Subramanian, Vora, Gentile, Stahelin, & Chalfant, 2007) As PIP2 is a calcium-
independent, allosteric activator of cPLA2α, the loss of association with C1P may “shift” 
the enzyme to PIP2-enriched membranes, and lead to the utilization of a different 
substrate pool linked to Five Lipoxygenase (5-LO) utilization of the released free fatty acid 
(Fig. 2.11). Our data demonstrating co-localization of the mut-cPLA2α with FLAP in 
contrast to the WT enzyme supports this temporal, “shifting” theory. It is intriguing to 
hypothesize that this shift from C1P- to PIP2-mediated regulation of cPLA2α is a key step 
in the transition from the inflammatory stage of wound healing to the proliferation stage. 
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Future studies are on-going to examine this new hypothesis in depth, which will help 
elucidate unknown interactions surrounding the temporal interplay and agonist specificity 
of these different regulatory mechanisms of cPLA2α.  
 One conundrum in this study is the finding that C1P is an inhibitor of pDF migration 
via association with cPLA2α. Indeed, a number of laboratories have reported that 
exogenous C1P treatment induces the migration of various cell types including 
fibroblasts.(C. Kim, Liu, Kucia, & Ratajczak, 2011; Ordoñez, Rivera, Presa, & Gomez-
Muñoz, 2016; Wijesinghe et al., 2014) Our findings in this study as well as a previous 
report examining cellular models of ceramide kinase ablation suggest that these 
differences are likely due to the cellular context, with C1P derived from ceramide kinase 
localized to more internal membranes and acting as a negative regulator of cellular 
migration. On the other hand, C1P possibly generated via other anabolic pathways at the 
plasma membrane or other cellular localities may enhance migration via association with 
factors such as annexins as reported by Kester and co-workers.(Hankins et al., 2013) As 
exogenous C1P treatment tends to only significantly increase the C1P content of the 
plasma membrane in a number of cell types, a “pool” of C1P at this cellular membrane 
may be the “driver” of migration observed by others. At least one additional anabolic 
pathway for C1P generation exists in mammalian cells, since CERK ablation only reduces 
the cellular context of C1P approximately 50%. As to the identity of this unknown anabolic 
pathway, the generation of C1P via an S1P-acylase has been reported.(Binoda, 
Portoukalian, Schmitt, Rodriguez-Lafrasse, & Ardail, 2004) Additional studies are needed 
to elucidate these anabolic pathways for C1P as well as distinct cellular functions for 
individual pathways in various cellular contexts and cellular localities. 
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 Another intriguing, but as of yet, unexplainable observation is the dramatic 
differential localization of FLAP in the cPLA2α KI pDFs as compared to WT. Indeed, FLAP 
was localized primarily in the nucleus in WT pDFs, in complete contrast to its cytoplasmic 
localization in cPLA2α KI cells. Very little is known about FLAP translocation, as it was 
initially considered to be only a nuclear membrane protein, but recent work by Bozza and 
colleagues (Bozza, Magalhães, & Weller, 2009) has demonstrated that FLAP can be 
found in organelles such as lipid bodies (lipid droplets). This was of note due to the 
importance that lipid bodies play in many cellular signaling pathways, such as lipid 
metabolism, membrane trafficking, and regulation of inflammation. Indeed, 
phosphoinositides play key roles in the signaling platforms related to lipid bodies such as 
cellular trafficking and autophagy (Skotland, Hessvik, Sandvig, & Llorente, 2018; Wallroth 
& Haucke, 2018), which supports our hypothetic model of mut-cPLA2α shifting to these 
cytoplasmic localities via association with phosphoinositides and co-localizing with FLAP. 
This concentration of enzymes as well as the altered localization of FLAP allows for 
greater colocalization with the mutant cPLA2α observed in our cPLA2α-KI, which in turn 
may explain increased HETE production seen in the cPLA2α-KI. 
 In conclusion, this study shows that the C1P/cPLA2α interaction plays an important 
role in the wound healing process, which was tested through a series of rigorous 
experiments. First, we demonstrated that fibroblasts migrated more rapidly into the healed 
wounds of cPLA2α-KI mice compared to WT and cPLA2α-KO mice. Second, we 
demonstrated that increased cell migration was coupled to increased type I collagen 
deposition as well as increased tensile strength of healed wounds in cPLA2α-KI mice. 
Third, pDFs from these genotypes showed increased migration velocity among cPLA2α-
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KI cells compared to WT and cPLA2α-KO cells. Fourth, we identified differences in the 
eicosanoid profile of all three genotypes, and demonstrated that exogenous addition of 
5-HETE recapitulated the migration phenotype previously observed in the cPLA2α-KI 
pDFs. Lastly, we used enforced gene expression and specific inhibitors to demonstrate 
that the observed phenotype was not due to altered expression or adaptation issues, but 
rather due to the genetic ablation of the C1P/cPLA2α interaction. This study shows the 
importance of lipids, and more specifically eicosanoids, in the wound healing process and 
should act as a stepping stone for further research in the development of drugs, to 
increase the healing rate and strength of wounds. 
 
2.3 Methods and Materials 
Western Immunoblotting 
 Western blot analysis was performed as described previously (DeLigio, Lin, 
Chalfant, & Park, 2017; Shapiro et al., 2016; Vu et al., 2016) using 20 µg of protein from 
each extract. Monoclonal anti-cPLA2α (Santa Cruz Biotech - cPLA2α- (4-4B-3C); 1:200), 
rabbit polyclonal anti- cPLA2α (Abcam - cPLA2α - (ab135825); 1:200), and rabbit 
polyclonal anti-FLAP (Abcam - FLAP - (ab85227); 1:800), was used to identify the protein 
of interest. Anti β-actin antibody (1:5000) (Cell Signaling) was used as a normalizing 
factor.  
RNA Isolation, Reverse Transcription-PCR, and Quantitative PCR 
 To evaluate expression of cPLA2α, a RNeasy kit (Qiagen) was used to isolate total 
RNA as previously described(Shultz et al., 2012). Next total RNA (1µg) was reverse-
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transcribed using Superscript III reverse transcriptase (Invitrogen) according to the 
manufacturer’s protocol. Following cDNA synthesis cPLA2α expression was monitored 
using quantitative PCR and TaqMan technology (Applied Biosystems) specific to cPLA2α 
with GAPDH as a control/normalizing factor. Premixed primer-probe sets, and TaqMan 
Universal PCR master mix were purchased from Applied Biosystems, and the cDNA was 
amplified using CFX Connect real-time PCR detection system (Bio-Rad). Gene 
expression levels were calculated by the ΔΔCt method, normalized to GAPDH 
expression, and presented as fold of mean values ± SD.  
PCR-based identification of WT, cPLA2α-KI, and cPLA2α-KO 
 Genotyping of WT, cPLA2α-KI, and cPLA2α-KO mice was performed by first 
collecting genomic DNA using an Accustart II genotyping kit followed by polymerase chain 
reaction (PCR) using the following primers: PLA2 58780-58757, 5’-TGCCAGATGT-
GAACTTACTTCCAG-3’; PLA2 58534-58556, 5’-TGAGGGTCGTGCTGTAGAGTTAG-3’; 
and SV40 2590-2567 5’-CTGCATTCTAGTTGTGGTTTGTCC-3’. 50ng of genomic DNA 
was used for each reaction along with the following primer concentrations, cPLA2α-KI: 0.2 
μmol/L PLA2 58780-58757 and 0.2 μmol/L PLA2 58534-58556, cPLA2α KO: 0.2 μmol/L 
PLA2 58780-58757, 0.1 μmol/L PLA2 58534-58556, and .1 μmol/L SV40 2590-2567 
additionally the following reaction cycles were repeated 33 times, 94°C for 1 min, 59°C 
for 1 min, and 72°C for 2 min. Reaction products expected are as follows WT: 237bp, 
cPLA2α-KI: 412bp, and cPLA2α KO:361bp and were examined using a 2% agarose gel. 
Isolation of mouse dermal fibroblasts 
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 Primary mouse dermal fibroblasts (pDFs)were isolated from 10-week-old WT, 
cPLA2α-KI, and cPLA2α-KO C57/Blk6 males as previously described.(Seluanov, Vaidya, 
& Gorbunova, 2010)  Once harvested cells were cultured using high glucose DMEM 
(Gibco) supplemented with 20% FBS (Gibco) and 2% penicillin/streptomycin (Bio 
Whittaker) at standard incubation conditions.  Cells were not used after passage 5.  
Soluble collagen assay  
 Primary DFs obtained from WT, cPLA2α-KI, and cPLA2α-KO mice were plated at 
a density of 5.0 x 103/well of a 96 well plate in high glucose DMEM supplemented with 
20% FBS (GIBCO) and 2% penicillin/streptomycin (Bio Whittaker) and allowed to adhere 
at grow standard incubation conditions for 24 h. Following the 24-hour incubation period, 
collagen deposition was measured using a soluble collagen assay from Cell BioLabs. 
Briefly, media was removed, and cells were allowed to dry overnight in a 37°C oven. 
Following the drying period, cells were washed with distilled water and then stained using 
Sirius Red Reagent. After a 60 min incubation the Sirius Red Reagent was removed, and 
cells were washed with 5% acetic acid four times. Extraction solution was then applied to 
each well and allowed to incubate at room temperature for 30 min. Following the 
incubation period, 100 µl of extraction reagent was removed from each well and placed 
in a new well. Collagen levels were then assessed by absorbance at 540-560 nm in each 
well.   
Excisional biopsy punch 
 6 mm excisional wounds were generated by first anesthetizing 10-week-old WT, 
cPLA2α-KI, and cPLA2α-KO C57/Blk6 males and shaving their dorsum, after the dorsum 
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was shaved, alcohol and iodine was used to prep the surgical site, at which point a 6 mm 
biopsy punch (Miltex) was used to create two 6 mm hole punches on the dorsum of the 
mice.  Silicone stints were then place around the wound and a combination of 6 sutures 
and glue were used to hold said stints in place. Wounds were dressed using Tegaderm 
(3M Medical) and imaged over the course of 14 days. Wound images were analyzed 
using the Fiji image J bundle.  
Histology 
 6 mm excisional wounds were generated by first anesthetizing 10-week-old WT, 
cPLA2α-KI, and cPLA2α-KO C57/Blk6 males and shaving their dorsum, after the dorsum 
was shaved, alcohol and iodine was used to prep the surgical site, at which point a 6 mm 
biopsy punch (Miltex) was used to create two 6mm hole punches on the dorsum of the 
mice.  Silicone stints were then place around the wound and a combination of 6 sutures 
and glue were used to hold said stints in place. Wounds were dressed using Tegaderm 
(3M Medical) and allowed to heal for 10 days.  After 10 days, wounds were excised and 
prepared for histological evaluation using the following procedure.  Excised wounds were 
fixed by placing them in 4% paraformaldehyde for 24 hours, following fixation the wound 
was placed in a cassette that allowed for the dehydration of the tissue, followed by 
clearing of the tissue using xylene (Fisher brand), and finally imbedding the tissue in 
paraffin wax. Sections (5 µm) of the paraffin block were placed on clear glass slides for 
further treatment and staining. Staining and probing for Masson’s trichrome, picrosirius 
red, and Hsp47 (rabbit polyclonal anti-Hsp47 (Abcam – Hsp47 - (ab109117); 1:4000)) 
were performed by Histo-Scientific Research Laboratories Inc.  
Immunocytochemistry 
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 Primary dermal fibroblasts from WT, cPLA2α-KI, and cPLA2α-KO were seeded into 
24 well tissue culture plates that contained round cover slips (Electron Microscopy 
Science) at a density of 3.5 x 104/well and fixed for 20 min in 4% paraformaldehyde, 
following 4% paraformaldehyde fixation cells were washed 3x in PBS and then treated 
with 100% ice cold methanol for 5 min. Following the fixation and methanol treatment 
cells were immunolabeled as previously described(Benusa, George, Sword, DeVries, & 
Dupree, 2017; Vu et al., 2013) with the following antibodies: mouse monoclonal anti-
cPLA2α (Santa Cruz Biotech - cPLA2α- (4-4B-3C); 1:50), rabbit polyclonal anti-FLAP 
(Abcam - FLAP - (ab85227); 1:100), mouse monoclonal anti-calnexin (Abcam - calnexin 
- (ab22595); 1:50), and rabbit polyclonal anti-Hsp47 (Abcam – Hsp47 - (ab109117); 
1:4000).  All secondary antibodies were obtained from Invitrogen Life Technologies 
(Grand Island, NY; Alexa™ Fluor) and used at a dilution of 1:500. 
Wound Tensile strength 
 20 mm incisional wounds were generated by first anesthetizing 10-week-old WT, 
cPLA2α-KI, and cPLA2α-KO C57/Blk6 males and shaving their dorsum. After the dorsum 
was shaved, alcohol and iodine were used to prep the surgical site, at which time a ruler 
& marker were used to mark a 20 mm line. A scalpel (Bard-Parker) was used to form a 
single sagittal incision along the line on the dorsum. Wounds were dressed using butterfly 
stitches and self-adhesive medical tape. Mice were monitored, and any mice that 
removed their dressing within 72 h were removed from the study. Wounds were allowed 
to heal for 10 days, at which point, the wound was excised and trimmed into a bar bell 
shape, so that the midsection was 5 mm wide and the length was 20 mm. Once trimmed, 
samples were placed on a materials testing equipment, MTS Synergie 100 (MTS 
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Corporation, Eden Prairie MN) and stretched to failure at a displacement rate of 
10mm/minute, as standard protocol performed previously for wound tensile 
strength.(Mohammed et al., 2015) 
Scratch-induced mechanical trauma of fibroblasts 
 Primary DF’s obtained from WT, cPLA2α-KI, and cPLA2α-KO mice were plated at 
a density of 2 x 106 on 10 cm tissue culture plates in high glucose DMEM supplemented 
with 20% FBS (GIBCO) and 2% penicillin/streptomycin (Bio Whittaker) and left overnight 
to adhere at standard incubation conditions.  Following the overnight incubation cells were 
rested in 2% FBS (GIBCO) 2% penicillin/streptomycin (Bio Whittaker) high glucose 
DMEM (Gibco) for 2 hours.  After the 2-hour resting period the media was exchanged 
with 0% FBS (GIBCO) 2% penicillin/streptomycin (Bio Whittaker) high glucose DMEM 
(Gibco) and mechanical trauma was induced on the monolayer by performing scratched 
across the diameter of the plate in an asterisk pattern using 4 20 µl pipette tips on a 
multichannel micro pipettor. Media was taken for lipidomic analysis at multiple time points 
(0 h and 2 h).  
Eicosanoid Preparation and Analysis 
Eicosanoid Preparation 
 Eicosanoids were extracted using a modified extraction process from previously 
described. (Blaho, Buczynski, Brown, & Dennis, 2009; Simanshu et al., 2013) Media from 
cells (4 mL) was combined with an IS mixture comprised of 10% methanol (400 μl) and 
glacial acetic acid (20 μl) before spiking with internal standard (20 μl) containing the 
following deuterated eicosanoids (2 pmol/μl, 40 pmol total) (All standards purchased from 
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Cayman Chemicals): (d4) 6keto-Prostaglandin F1α, (d4) Prostaglandin F2α, (d4) 
Prostaglandin E2, (d4) Prostaglandin D2, (d8) 5-Hydroxyeicosa-tetranoic acid (5-HETE), 
(d8) 12-Hydroxyeicosa-tetranoic acid (12-HETE) (d8) 15-Hydroxyeicosa-tetranoic acid 
(15-HETE), (d6) 20-Hydroxyeicosa-tetranoic acid (20-HETE), (d11) 8,9 Epoxyeicosa-
trienoic acid, (d8) 14,15 Epoxyeicosa-trienoic acid, (d8) Arachidonic acid, (d5) 
Eicosapentaenoic acid, (d5) Docosahexaenoic acid, (d4) Prostaglandin A2, (d4) 
Leukotriene B4, (d4) Leukotriene C4, (d4) Leukotriene D4, (d4) Leukotriene E4, (d5) 
5(S),6(R)-Lipoxin A4, (d11) 5-iPF2α-VI, (d4) 8-iso Prostaglandin F2α, (d11) (±)14,15-DHET, 
(d11) (±)8,9-DHET, (d11) (±)11,12-DHET, (d4) Prostaglandin E1, (d4) Thromboxane B2, (d6) 
dihmo gamma linoleic acid, (d5) Resolvin D2, (d5) Resolvin D1, (d5) Maresin2, and (d5) 
Resolvin D3. Samples and vial rinses (5% MeOH; 2 ml) were applied to Strata-X SPE 
columns (Phenomenex), previously washed with methanol (2 ml) and then dH2O (2 ml). 
Eicosanoids eluted with isopropanol (2 ml), were dried in vacuuo and reconstituted in 
EtOH:dH2O (50:50;100 μl) prior to UPLC ESI-MS/MS analysis. 
Analysis of Eicosanoids by UPLC ESI-MS/MS 
 Eicosanoids were separated using a Shimadzu Nexara X2 LC-30AD coupled to a 
SIL-30AC auto injector, coupled to a DGU-20A5R degassing unit in the following way as 
previously described by us.(Simanshu et al., 2013) A 14 minute, reversed phase LC 
method utilizing an Acentis Express C18 column (150mm x 2.1mm, 2.7µm) was used to 
separate the eicosanoids at a 0.5 ml/min flow rate at 40°C as previously described by 
us(Simanshu et al., 2013). The column was equilibrated with 100% Solvent A 
[acetonitrile:water:formic acid (20:80:0.02, v/v/v)] for 5 min and then 10 µl of sample was 
injected. 100% Solvent A was used for the first two minutes of elution. Solvent B 
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[acetonitrile:isopropanol:formic acid (20:80:0.02, v/v/v)] was increased in a linear gradient 
to 25% Solvent B at 3 min, to 30% at 6 min., to 55% at 6.1 min, to 70% at 10 min, and to 
100% at 10.10 min. 100% Solvent B was held constant until 13.0 min, where it was 
decreased to 0% Solvent B and 100% Solvent A from 13.0 min to 13.1 min. From 13.1 
min to 14.0 min. Solvent A was held constant at 100%.  
Eicosanoids were analyzed via mass spec using an AB Sciex Triple Quad 5500 Mass 
Spectrometer as previously described by us (Simanshu et al., 2013). Q1 and Q3 were set 
to detect distinctive precursor and product ion pairs. Ions were fragmented in Q2 using 
N2 gas for collisionally induced dissociation. Analysis used multiple-reaction monitoring 
in negative-ion mode. Eicosanoids were monitored using precursor → product MRM 
pairs. The mass spectrometer parameters used were: Curtain Gas: 20; CAD: Medium; 
Ion Spray Voltage: -4500V; Temperature: 300°C; Gas 1: 40; Gas 2: 60; Declustering 
Potential, Collision Energy, and Cell Exit Potential vary per transition. 
Migration analysis of fibroblasts 
 Cells were seeded into 24 well tissue culture plates at a density of 7.5 x 104 and 
allowed to grow to confluence. Once a confluent monolayer was achieved cells were 
placed in 2% FBS (GIBCO)/2% penicillin/streptomycin (Bio Whittaker) high glucose 
DMEM media and allowed to rest for 2-hours. After the 2-hour resting period, the media 
was exchanged with 0% FBS (GIBCO) high glucose DMEM media (Gibco), and 
mechanical trauma was induced on the monolayer by performing scratched across the 
diameter of each well using a 20µl pipette tip. Cells were observed using a live cell 
incubation chamber mounted on a Keyence BZ-X710 microscope, which took images 
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every 3 min for 24hr. Migration Velocity and meandering index were calculated using the 
Keyence VW-9000 motion analysis software. 
Exogenous addition of eicosanoids on dermal fibroblasts 
 Cells were seeded into 24-well tissue culture plates at a density of 7.5 x 104 and 
allowed to grow to confluence.  Once a confluent monolayer was achieved, cells were 
placed in 2% FBS (GIBCO) High Glucose DMEM media (GIBCO) containing the addition 
of various eicosanoids at the following concentrations (20 ng/mL PGE2, 0.25ng/mL 5-
HETE, 0.5ng/mL 5-HETE, 1 ng/mL 5-HETE, and 5 ng/mL 20-HETE) and allowed to rest. 
After the 2-hour resting period, the media was exchanged with 0% FBS (GIBCO), high 
glucose DMEM media (GIBCO) containing the addition of various eicosanoids at the 
following concentrations (20 ng/mL PGE2, 0.25ng/mL 5-HETE, 0.5ng/mL 5-HETE, 1 
ng/mL 5-HETE, and 5 ng/mL 20-HETE). Following the media exchange a single scratch 
was performed down the diameter of each well using a 20 l pipette tip and cells were 
observed using a live cell incubation chamber mounted on a Keyence BZ-X710 
microscope, which took images every 3 min for 24 hr. Migration velocity and meandering 
index were calculated using the Keyence VW-9000 motion analysis software 
Adenoviral treatment of fibroblasts 
Migration velocity studies 
 Cells were seeded into 24-well, tissue culture plates at a density of 7.5 x 104 and 
allowed to grow to confluence. The following day, cells were infected with adenovirus 
containing either GFP-cPLA2α (WT), GFP-cPLA2α(R57A/K58A/R59A), or an adeno-
CMV-control virus (100, 100, and 50 multiplicity of infection, respectively) After 72 hours 
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cells were placed in 2% FBS (GIBCO) High Glucose DMEM media (GIBCO) for two hours. 
Following the resting period media was exchanged with 0% FBS (GIBCO) 2% 
penicillin/streptomycin (Bio Whittaker) high glucose DMEM (GIBCO). Following the media 
exchange a single scratch was performed down the diameter of each well using a 20 µl 
pipette tip and cells were observed using a live cell incubation chamber mounted on a 
Keyence BZ-X710 microscope, which took images every 3 min for 24hr. Migration 
Velocity and meandering index were calculated using the Keyence VW-9000 motion 
analysis software. 
Lipid profile studies 
 pDFs obtained from WT, cPLA2α-KI, and cPLA2α-KO mice were plated at a density 
of 2 x 106 on 10 cm tissue culture plates in high glucose DMEM supplemented with 20% 
FBS (GIBCO) and 2% penicillin/streptomycin (Bio Whittaker) and left overnight to adhere 
at standard incubation conditions.  The following day cells were infected with adenovirus 
containing either GFP-cPLA2α (WT), GFP-cPLA2α (R57A/K58A/R59A), or an adeno-
CMV-control virus (100, 100, and 50 multiplicity of infection, respectively) as described 
previously described by us.(Lamour & Chalfant, 2008) After 72 hours cells were placed 
in 2% FBS (GIBCO), High Glucose DMEM media (GIBCO). After the 2-hour resting period 
the media was exchanged with 0 FBS (GIBCO) High Glucose DMEM media (GIBCO) and 
mechanical trauma was induced on the monolayer by performing scratches across the 
diameter of the plate in an asterisk pattern using 4X20 µl pipette tips on a multichannel 
micro pipettor. Media was taken for lipidomic analysis at multiple time points (0 h and 2 
h). 
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Electron microscopy 
 6 mm excisional wounds were generated by first anesthetizing 10-week-old WT, 
cPLA2α KI, and cPLA2α KO C57BL/6 males and shaving their dorsum, after the dorsum 
was shaved, alcohol and iodine was used to prep the surgical site, at which point a 6mm 
biopsy punch (Miltex) was used to create two 6mm hole punches on the dorsum of the 
mice.  Silicone stints were then place around the wound, and a combination of 6 sutures 
and glue were used to hold said stints in place. Wounds were dressed using Tegaderm 
(3M Medical) and allowed to heal for 10 days. After 10 days, mice were transcardially 
perfused with a phosphate buffered solution containing 5% glutaraldehyde and 4% 
paraformaldehyde (pH 7.3). Whole carcasses were post-fixed for 2 weeks in the same 
solution to ensure optimal tissue preservation. For all studies, 6 mm hole biopsies were 
taken of the wounded area processed for standard transmission electron microscopic 
analysis as previously described.(Moyon et al., 2016) Briefly, the skin sections were post-
fixed in 1% osmium tetroxide buffered in 0.1M cacodylate, dehydrated in increasing serial 
dilutions of cold ethanol and infiltrated and embedded in PolyBed resin. Each skin section 
was oriented for transverse analysis. One micron and ultrathin sections were collected 
and stained with sodium borate containing 0.1% toluidine blue. 0.1% methylene blue and 
0.1% azure blue and uranyl acetate and lead citrate respectively. For the EM analysis, a 
JEOL JEM 1400 transmission electron microscope equipped with a Gatan Ultrascan 
digital camera system was employed to collect a minimum of 4 electron micrographs per 
animal. These images were used to determine the collagen rod diameter as described by 
Khorasani and colleague.(Khorasani et al., 2011) 
Small molecule inhibitor studies 
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Migration velocity studies 
 Cells were seeded into 24-well, tissue culture plates at a density of 7.5 x 104 and 
allowed to grow to confluence.  Once a confluent monolayer was achieved cells were 
placed in 2% FBS (GIBCO) High Glucose DMEM media (GIBCO) containing the addition 
of either MK886 (7.5 nM) (cayman chem), pyrrophenone (10 nM) (cayman chem), or a 
combination of MK886/pyrrophenone and 5-HETE (1 ng/ml) for two hours. Following the 
resting period media was exchanged with 0% FBS (GIBCO) 2% penicillin/streptomycin 
(Bio Whittaker) high glucose DMEM (GIBCO) containing the addition of either MK886 (7.5 
nM) (Cayman Chemical), pyrrophenone (10 nM) (cayman chemical), or a combination of 
either MK886/pyrrophenone and 5-HETE (1 ng/ml). Following the media exchange, a 
single scratch was performed down the diameter of each well using a 20 µl pipette tip and 
cells were observed using a live cell incubation chamber mounted on a Keyence BZ-X710 
microscope, which took images every 3 min for 24 h. Migration velocity and meandering 
index were calculated using the Keyence VW-9000 motion analysis software. 
Lipid profile studies 
 pDFs obtained from WT, cPLA2α KI, and cPLA2α KO mice were plated at a density 
of 2 x 106 on 10 cm tissue culture plates in high glucose DMEM supplemented with 20% 
FBS (GIBCO)/2% penicillin/streptomycin (Bio Whittaker) and left overnight to adhere at 
standard incubation conditions.  Following the overnight incubation, cells were rested in 
2% FBS (GIBCO), High Glucose DMEM media (GIBCO) containing the addition of 
pyrrophenone (10nm) (cayman chem). After the 2-hour resting period the media was 
exchanged with 0% FBS (GIBCO), High Glucose DMEM media (GIBCO) containing the 
addition of pyrrophenone (10 nM) (Cayman Chemical) and mechanical trauma was 
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induced on the monolayer by performing scratches across the diameter of the plate in an 
asterisk pattern using 4X20 µl pipette tips on a multichannel micro pipettor. Media was 
taken for lipidomic analysis at multiple time points (0 h and 2 h).  
Ethical considerations 
 The mouse studies were undertaken under the supervision and approval of the 
VCU IACUC (Protocol# AM10089) and USF IACUC (Protocol# IS00004094 and 
IS00004110) following standards set by the Federal and State government. The animal 
assurance number for VCU is #D16-00180 (A3281-01). USF and VCU are fully accredited 
by AAALAC International as program #000434 and  #000036 respectively, is managed in 
accordance with the Guide for the Care and Use of Laboratory Animals, the Animal 
Welfare Regulations, the PHS Policy, the FDA Good Laboratory Practices, and the 
IACUC Principles and Procedures of Animal Care and Use, has an assurance #D16-
00589 (A4100-01) on file with OLAW/PHS and maintains registration #58-R-0015 with 
USDA/APHIS/AC.   
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Figure 2.1  Strategy and design of the novel cPLA2α KI mice.   
 (A) A schematic representation of the cassette inserted at the beginning of 
endogenous exon 4 used to generate both the cPLA2α KI and cPLA2α KO mice used in 
this study.  The cassette contains a puromycin resistance gene followed by a premature 
stop codon, both of which are flanked by two loxP sites. Additionally, the cassette contains 
a triple mutation at the C1P binding site, R57A, K58A, R59A at the beginning of exon number 
four. Following the addition of CRE recombinase, the puromycin resistance gene and 
premature stop codon are excised allowing for the production of cPLA2α with the mutated 
C1P binding site.  (B) WT, cPLA2α KI, and cPLA2α KO primary dermal fibroblasts (2.0 x 
106 cells/100-mm plate) were allowed to grow for 24 hours and then harvested for RNA 
collection.  RNA from WT, cPLA2α KI, and cPLA2α KO primary dermal fibroblasts was 
converted to cDNA and used for quantitative PCR analysis using primers specific to the 
cPLA2α gene (applied biosciences TaqMan). (C) Genotypic analysis of WT, cPLA2α KI, 
and cPLA2α KO was performed by collecting DNA from mouse tails, analyzing via PCR, 
and examining the resulting products using gel electrophoresis. When using the cassette 
specific primer sets, three bands are possible the WT at 237 bp, the cPLA2α KI at 412 bp, 
and cPLA2α KO at 361 bp. Samples were compared using ANOVA followed by Tukey's 
post-hoc test. Data shown are means + SD, n = 3 samples per group, ****P< 0.0001. 
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Figure 2.2  Ablation of the C1P/cPLA2α interaction does not affect the in vivo wound 
closure rate.  
 Closure rate of acute wounds in C57/BLK6 WT, cPLA2α KI, and cPLA2α KO mice 
were observed using the stinted excisional wound model previously described by Wang 
and colleagues.(Wang et al., 2013b) (A) shows no significant difference in wound closure 
rate between C57BL/66 WT, cPLA2α KI, and cPLA2α KO mice. (B) Percent opened wound 
of C57/BLK6 WT, cPLA2α KI, and cPLA2α KO over course of 14 days. Samples were 
compared using ANOVA followed by Tukey's post-hoc test. Data shown are means + SD, 
n = 5 mice per group.  
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Figure 2.3 Histological evaluation of healed wounds from WT, cPLA2α KI, and 
cPLA2α KO mice demonstrated a distinct phenotypical difference.  
 Using the stinted excisional wound model as previously described (Wong, Sorkin, 
Glotzbach, Longaker, & Gurtner, 2011a) the histology of healed wounds from WT, cPLA2α 
KI, and cPLA2α KO mice were observed. (A) Representative Masson’s trichrome stained 
sections from WT, cPLA2α KI, and cPLA2α KO mice 10 days post excisional wounding 
demonstrated significantly increased levels of collagen (dark blue color) and infiltrating 
cells (cell nuclei (purple)) in cPLA2α KI mice as compared to both WT and cPLA2α KO 
mice. (B) Wound sections were probed for the fibroblast marker Hsp47, which 
demonstrated that cPLA2α KI mice had significantly increased levels of fibroblasts in 
healed acute wounds. (C) Further examination of the wound sections using brightfield 
microscopy and Picrosirius red demonstrated differential levels of collagen deposition in 
cPLA2α KI mice (collagen Type I = dark pink; collagen Type III = light pink). (D) 
Additionally, the use of polarized light microscopy revealed increased levels of Type I 
collagen (dark red) versus Type III collagen (yellow) in cPLA2α KI mice when compared 
to both the WT and cPLA2α KO mice. (E) Graphical representation of the cell counts 
performed on Hsp47 probed sections. (F) Graphical representation of the ratio of type I 
vs. type III collagen in Picrosirius red stained sections examined under polarized light. 
Samples were compared using ANOVA followed by Tukey's post-hoc test. Data shown 
are means + SD, n = 4 mice per group, *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001. 
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Figure 2.4 Healed wounds from WT, cPLA2α KI, and cPLA2α KO mice demonstrate 
differences in collagen rod diameter and wound tensile strength.  
 (A) Transmission electron microscopy (TEM) images of stinted excisional wounds 
allowed to heal for 10 days were collected from WT, cPLA2α KI, and cPLA2α KO mice. 
These images demonstrated a difference in the rod diameter profile of cPLA2α KI as 
compared to both WT and cPLA2α KO mice. (B) Graphical representation of data from 
TEM images. (C) Further exploring the phenotype, a 2 cm incisional wound was made on 
the shaved dorsum of WT, cPLA2α KI, and cPLA2α KO mice and allowed to heal for 10 
days. Healed wounds were then collected, and wound tensile strength was measured 
on materials testing equipment. Samples were compared using ANOVA followed by 
Tukey's post-hoc test. Data shown are means + SD, n = 2-3 mice per group for TEM, n = 
4-7 mice per group for wound tensile strength, *P< 0.05, **P< 0.01. 
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Figure 2.5 The loss of the C1P/cPLA2α interaction causes an increase in migration 
velocity and collagen deposition in primary dermal fibroblasts.   
 (A-C) Actin distribution was examined in primary dermal fibroblasts collected from 
WT, cPLA2α KI, and cPLA2α KO mice, and no significant differences were observed 
between the three genotypes. (D, E, and F) Migration velocity in all three genotypes was 
observed as described in the methods using a Keyence bz-x710 microscope with live cell 
incubation chamber attachment. When examining migration in all three genotypes, a 
significant difference in migration velocity was observed in the cPLA2α KI pDFs when 
compared to WT and cPLA2α KO sample. (G) In addition, we examined the collagen 
deposition rate of WT, cPLA2α KI, and cPLA2α KO pDFs and discovered that at 24hr post 
plating, cPLA2α KI pDFs deposited collagen with an increased rate as compared to both 
WT and cPLA2α KO pDFs. Samples were compared using ANOVA followed by Tukey's 
post-hoc test. Data shown are means + SD, n = 6-12 samples per group, *P< 0.05, **P< 
0.01, ***P< 0.001, ****P< 0.0001. 
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Figure 2.6 Genetic ablation of the C1P/cPLA2α interaction affects eicosanoid 
synthesis in primary dermal fibroblasts and healed excisional wounds.   
 In order to examine the lipid profile of primary dermal fibroblasts from WT, cPLA2α 
KI, and cPLA2α KO mice, cells where cultured as described in the experimental 
procedures. Media containing secreted eicosanoids were quantified at 2 hours post-injury 
via HPLC ESI-MS/MS as described in Experimental Procedures.  (A) Significant decrease 
in PGE2 is seen in both cPLA2α KI and cPLA2α KO pDFs as compared to the WT control 
cells. (B) Complete lipid profile of WT, cPLA2α KI, and cPLA2α KO pDFs shown as fold 
change in comparison to WT controls. (C) cPLA2α KI pDFs display a significant increase 
of 5-HETE as compared to both WT and cPLA2α KO pDFs. In order to further our 
investigation of the of the C1P/cPLA2α interaction on eicosanoid formation, an in vivo 
approach was used in where 6 mm biopsy punches were used to remove skin from stinted 
excisional wounds that had been allowed to heal for 10 days. The skin was than 
homogenized via an Omni Tissue Homogenizer on ice and processed for lipid extraction 
as previously described in the experimental procedures. (D and E) Similar to the in vitro 
study increases in 5-HETE were observed in samples collected from cPLA2α KI mice as 
compared to both WT and cPLA2α KO. Samples were compared using ANOVA followed 
by Tukey's post-hoc test. Data shown are means + SD, n = 6-8 samples per group for in 
vitro studies, n = 3 samples per group for in vivo studies, *P< 0.05, **P< 0.01, ***P< 0.001, 
****P< 0.0001. 
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Figure 2.7 Viral recapitulation “rescues” the cPLA2α KI phenotype in cPLA2α KO 
pDFs.  Evaluation of cPLA2α expression via western immunoblotting demonstrated 
a significant difference in the levels of cPLA2α in cPLA2α KI pDFs. (B) Primary dermal 
fibroblasts from cPLA2α KO mice were cultured and treated with either GFP-cPLA2α (WT 
Virus), GFP- cPLA2α (R57A/K58A/R59A: mut-cPLA2α and Mutant virus), or CMV-GFP 
(CMV Control Virus)-expressing adenovirus as described previously (Lamour et al., 2009) 
and in the Experimental Procedures. Using the previously described adenoviral 
expression system(Lamour et al., 2009), equal levels of either WT or mut-cPLA2α were 
expressed in cPLA2α KO pDFs as demonstrated by western immunoblot analysis.  (C,D)  
Media containing secreted eicosanoids from cPLA2α KO pDFs treated with GFP-cPLA2α 
(WT), GFP-cPLA2α (R57A/K58A/R59A), or CMV-GFP control virus were quantified at 2 
hours post-injury via HPLC ESI-MS/MS as previously described and as described in 
Experimental Procedures.(Wijesinghe et al., 2014) The addition of GFP-cPLA2α (WT) and 
GFP-cPLA2α (R57A/K58A/R59A) was able to recapitulate the previously observed lipid 
profiles in both cPLA2α WT and cPLA2α KI pDF’s. (D) Further, the increase in 5-HETE 
previously observed was also recapitulated in cPLA2α KO pDFs treated with GFP-cPLA2α 
(R57A/K58A/R59A) virus as compared to both the GFP-cPLA2α (WT)-and CMV control 
virus-treated cPLA2α KO pDFs. (E) Lastly, the migration velocity phenotype observed in 
cPLA2α KI pDFs was recapitulated by the addition of the GFP-cPLA2α (R57A/K58A/R59A) 
virus in contrast to both GFP-cPLA2α (WT) and CMV-GFP control virus. Samples were 
compared using ANOVA followed by Tukey's post-hoc test. Data shown are means + SD, 
n = 3-9 samples per group, *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001. 
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Figure 2.8 Exogenous addition of specific eicosanoids alters migration velocity in 
dermal fibroblasts.  
 Using the previously described migration velocity assay, pDFs from cPLA2α WT 
and cPLA2α KI mice were cultured in order to determine the effect of specific lipid 
mediators on migration velocity (A) Live cell imaging demonstrated that the exogenous 
addition of specific eicosanoids (i.e.,. PGE2 (20.00 ng/mL) and 5-HETE (1.00 ng/mL)) 
significantly altered the migration velocity of primary dermal fibroblasts. (B) 5-HETE was 
added to cPLA2α KO pDFs in a dose dependent manner (0.00 ng/ml, 0.25 ng/mL, 0.50 
ng/mL, and 1.00 ng/mL). Based on these data, 5-HETE does increase migration velocity 
at a lower dose in cPLA2α KO pDFs than WT. Samples were compared using ANOVA 
followed by Tukey's post-hoc test. Data shown are means + SD, n = 3-10 samples per 
group, *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001. 
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Figure 2.9 Small molecule inhibitors of cPLA2α and FLAP alter the migration 
velocity of cPLA2α KI dermal fibroblasts.  
 Using the previously described migration velocity assays, pDFs from cPLA2α WT, 
cPLA2α KI, and cPLA2α KO mice were cultured in order to determine the effect of various 
small molecule inhibitors on migration velocity. (A) The effects of pyrrophenone (10 nM) 
on the migration velocity of pDFs from cPLA2α WT, cPLA2α KI, and cPLA2α KO mice were 
examined. These data indicate that the cPLA2α inhibitor, pyrrophenone, had no effect on 
migration velocity in both the WT and cPLA2α KO pDFs, but had a significant effect on 
the cPLA2α KI pDFs as compared to control (cPLA2α WT pDFs). (B) pDFs were treated 
using the FLAP inhibitor, MK886 (7.5 nM), and the migration velocity was observed. In 
this test, MK886 had no effect on migration velocity in both the cPLA2α WT and cPLA2α 
KO pDFs, but had a significant effect on the cPLA2α KI pDFs as compared to control 
(cPLA2α WT pDFs). (C) Lastly, the migration velocity was observed in cPLA2α KI pDFs 
that were treated with a combination of either MK886 or pyrrophenone and 5-HETE (1 
ng/ml). Live cell imaging demonstrated that the addition of both MK886 and pyrrophenone 
significantly inhibited the decreased the migration velocity phenotype of cPLA2α KI DFs, 
while no significant difference was observed between the WT and cPLA2α KO DFs after 
treatment. Furthermore, the exogenous addition of 5-HETE was able to “rescue” the 
cPLA2α KI phenotype in both MK886 and pyrrophenone treated cells as no significant 
difference was observed in these pDFs when compared to control (cPLA2α KI DFs). 
Samples were compared using ANOVA followed by Tukey's post-hoc test. Data shown 
are means + SD, n = 4-10 samples per group, *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 
0.0001. 
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Figure 2.10 Primary dermal fibroblasts from cPLA2α KI mice demonstrate 
differential localization of cPLA2α and FLAP.  
 Primary dermal fibroblasts from WT, cPLA2α KI, and cPLA2α KO mice were 
cultured as described in the Experimental Procedures. pDFs were fixed, probed using 
anti-FLAP and anti-cPLA2α antibodies, and examined using confocal microscopy. (A and 
B) A shift in FLAP localization was observed in cPLA2α KI pDFs. FLAP had a more 
cytosolic localization in cPLA2α KI pDFs as compared to the nuclear localization observed 
in WT pDFs (yellow arrows). (A and C) Confocal microscopy also revealed a significant 
difference in the localization of cPLA2α in cPLA2α KI pDFs. cPLA2α in these pDFs 
demonstrated a cytosolic localization when compared to the Golgi/perinuclear localization 
observed for cPLA2α in WT pDFs (white arrows).  (D and E) Next FLAP expression was 
examined using western immunoblot analysis, which revealed a 35-45% decrease in 
FLAP expression in cPLA2α KI cells as compared to WT cells. Colocalization was 
determined using Pearson’s correlation index, samples were compared using an unpaired 
students t-test with Welch’s correction. Data shown are means + SD, n = 4-6 samples per 
group for confocal microscopy, n = 4 samples per group for western blot analysis, *P< 
0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001. 
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Figure 2.11 A schematic depiction of the current mechanistic hypothesis of cPLA2α 
regulation in the presence and absence of ceramide-1-phosphate. 
 (A) The current model of cPLA2α involves: (1) A stimulus increases intracellular 
calcium levels, as well as phosphorylation of cPLA2α (2) Translocation of cPLA2α, as 
well as association with C1P at intracellular membranes, such as the endoplasmic 
reticulum and Golgi (3) Upon membrane binding, cPLA2α preferentially cleaves 
arachidonic acid containing phospholipids at the sn-2 location generating free fatty acids 
(4) These free fatty acids, such as arachidonic acid are acted on by cellular enzymes, 
such as COX1/2, to produce various eicosanoids (eg. PGE2). (B) Based on the data 
presented we hypothesize the following model (1) A stimulus increases intracellular 
calcium levels, as well as phosphorylation of cPLA2α. Decreased translocation of cPLA2α 
to intracellular membranes and a preferred association with PIP2 (3) The differential 
binding of cPLA2α to PIP2 versus C1P, as well as the difference in localization, drive 
arachidonic acid utilization towards the 5-HETE pathway (4) Differential localization 
makes AA produced by mutant cPLA2α highly accessible to intracellular enzymes such 
as 5-LO and FLAP, which process arachidonic acid producing 5-HPETE (5) 5-HPETE is 
released and process by intracellular peroxidases generating 5-HETE. 
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Table 2.1 In vitro lipid profile from mechanically injured primary dermal fibroblasts 
from WT, cPLA2α KI, and cPLA2α mice.  
 Lipid levels of primary dermal fibroblasts from WT, cPLA2α KI, and cPLA2α KO 
mice where analyzed as described in the Experimental Procedures. Media containing 
secreted eicosanoids were quantified at 2 hours postinjury via HPLC ESI-MS/MS as 
described in Experimental Procedures.  Samples were compared using ANOVA followed 
by Tukey's post-hoc test. Data shown are means + SD, n = 6-8 samples per group 
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Table 2.2 In vivo lipid profile in acute excisional wounds from WT, cPLA2α KI, and 
cPLA2α KO mice.  
 Lipid levels were analyzed in acute excisional wounds generated by using 6 mm 
biopsy punches to remove skin from stinted excisional wounds that had been allowed to 
heal for 10 days. The wounds were homogenized via an Omni Tissue Homogenizer on 
ice, processed for lipid extraction, and analyzed by ESI-UPLC-MS/MS as previously 
described in the Experimental Procedures. Samples were compared using ANOVA 
followed by Tukey’s test. Data shown are means + SD, n = 3 samples per group 
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Table 2.3 The altered lipid profile in primary dermal fibroblasts from the cPLA2α KI 
mouse is cPLA2α-specific.  
 Lipid levels of Primary dermal fibroblasts from WT, cPLA2α KI, and cPLA2α KO 
mice were analyzed after treatment with pyrrophenone (10 nM), cells where cultured as 
described in the Experimental Procedures. Media containing secreted eicosanoids were 
quantified at 2 hours post-injury via HPLC ESI-MS/MS as described in Experimental 
Procedures. Samples were compared using ANOVA followed by Tukey’s test. Data 
shown are means + SD, n = 3 samples per group. 
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Chapter 3 
Background 
The C1P/cPLA2α in Chronic Wounds  
 
2.1 Introduction 
Chronic wounds are classified as wounds that are unable to progress through the 
stages of healing in an orderly and timely fashion, most often never progressing through 
the inflammatory phase. They are classified on a four point scale based on severity (Fig. 
3.1), with 1 being the least severe and having no open wound present to 4 in which the 
wound has extensive damage revealing bone and muscle at the wound site. (Rosenblum 
& Papamichael, 2016) Generally, chronic wounds arise from diabetic foot ulcers, venous 
leg ulcers, and pressure ulcers, but are certainly not limited to these injuries. (Frykberg & 
Banks, 2015)  To this end, chronic wounds are a growing concern in the medical 
community due to the extraordinary costs associated with treatment and care, estimated 
in excess of $20B (Järbrink et al., 2017; Nussbaum et al., 2018). While significant work 
has been done to further understand the pathologies that cause chronic wounds, more 
work is needed to advance the understanding of the molecular and cellular mechanisms 
involved in dysregulated wound closure, which often leads to chronic wounds. (Lazarus 
et al., 1994)  
Unfortunately an issue that continually arises when attempting to study chronic 
wounds is finding an appropriate model that recapitulates clinical features often seen in 
human wound healing. (Nunan, Harding, & Martin, 2014) With that understanding, 
Petreaca and colleagues generated a mouse model deficient in the TNFSF14/LIGHT 
gene (LIGHT-/-), which when injured generates wounds with similar pathologies to chronic 
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ulcer injuries seen in human patients.(Petreaca et al., 2012) Using this new model, Dhall 
and colleagues examined the role that various signaling lipids play in impaired healing. 
This work uncovered increases in various proinflammatory eicosanoids, which may act to 
hinder the healing process. In addition, they demonstrated that LIGHT-/- mice had 
increases in key eicosanoids involved in the coagulation cascade, which upregulated 
coagulation, reducing the bleeding time and increasing the inflammatory phase.(Dhall et 
al., 2015a) 
The work by Dhall and colleagues ties into work previously discussed in this 
dissertation. The LIGHT-/- mouse demonstrated increased proinflammatory eicosanoids 
leading to increased inflammation and a prolonged inflammatory phase. In contrast, our 
cPLA2α KI mouse displays decreased levels of these same proinflammatory eicosanoids, 
and increased levels of specific eicosanoids that enhance cellular infiltration into the 
wound. This led us to hypothesize that pressure ulcers in our cPLA2α KI mouse would 
heal at an increased rate compared to WT mice.   
Using our previously described cPLA2α KI mouse model we investigated the role 
of C1P/cPLA2α interactions in wound healing by examining chronic wounds. Excitingly, 
unlike the acute wound model, which did not reveal differences between the WT and 
cPLA2α KI, pilot studies using a modified version of a previously described pressure ulcer 
model (Stadler, Zhang, Oskoui, Whittaker, & Lanzafame, 2004) showed a significant 
increase in the rate of healing in cPLA2α KI mice as compared to WT mice. Additionally, 
neutrophil infiltration was increased in pressure ulcers from cPLA2α KI mice with 
significant numbers of neutrophils present as early as hour 2 as compared to hour 4 in 
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WT mice. These preliminary data demonstrate a potential role for the C1P/cPLA2α 
interaction in chronic wounds, as well as a potential therapeutic target in the future.  
 
2.2 Methods and Materials 
Generation of pressure ulcers 
 Pressure ulcers were generated in WT and cPLA2α KI C56/Blk6 females at 12 
weeks of age by first shaving their dorsum and cleaning with 70% ethanol. Once cleaned 
and dry skin on the dorsum was lifted to create a flap and placed between two magnets 
(need magnet info), magnets were allowed to stay in place for 16 hours (on cycle), at 
which point they were removed, and the skin flap was separated and allowed to lay flat 
on the mouse dorsum. The wounded area was allowed to rest for 16 hours (off cycle). 
This on/off cycle was performed two additional times for a total of 3 on/off cycles. 
Following the on/off cycles images are taken every 24 hours for 14 days.  
 
Histology 
 Pressure ulcers were generated in WT and cPLA2α KI C56/Blk6 females at 12 
weeks of age by first shaving their dorsum and cleaning with 70% ethanol. Once cleaned 
and dry skin on the dorsum was lifted up to create a flap and placed between two 
magnets, magnets were allowed to stay in place for 16 hours (on cycle), at which point 
they were removed, and the skin flap was separated and allowed to lay flat on the mouse 
dorsum. Pressure ulcers were excised at various time points (0, 2, 4, 8) and prepared for 
histological evaluation using the following procedure.  Excised wounds were fixed by 
placing them in 4% paraformaldehyde for 24 hours. Following fixation, the wound was 
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placed in a cassette that allowed tissue dehydration, followed by clearing of the tissue 
using xylene (Fisher brand), and finally imbedding the tissue in paraffin wax. 5 m 
Sections of the paraffin block were placed on clear glass slides for further treatment and 
staining. Sections were probed using rabbit polyclonal anti-myeloperoxidase (Abcam - 
myeloperoxidase - (ab45977); 1:100) following primary probing sections were treated and 
visualized using a HRP/DAB detection kit (Abcam – HRP/DAB (ABC)-(ab64261) per the 
manufactures protocol. 
 
Neutrophil isolation 
Neutrophils were isolated from the bone marrow of C57/BLK6 WT, cPLA2α KI, and 
cPLA2α KO mice via a percoll gradient isolation. Briefly, mice were sacrificed via CO2 
asphyxiation and soaked in 100% ethanol for 30 seconds. Following the ethanol cleaning 
step, femurs were removed from tissue and placed in HBSS prep media. Femurs were 
cleaned of any excess tissue and the end caps of each femur were removed, exposing 
the bone marrow. Using 1 ml of HBSS, femurs were flushed, and bone marrow was run 
through a 25g syringe to disperse clumps. The HBSS bone marrow suspension was 
centrifuged at 400g in room temp conditions for 5 min. The cell pellet was then 
resuspended in 6 ml of 0.2% NaCl for 45 seconds, following the lysis step, osmolarity was 
restored by adding 14 ml 1.2% NaCl. The new suspension was filtered using a cell strainer 
(70 micron) and re-pelleted at 400g in room temp conditions for 5 min and resuspended 
in 1 ml HBSS-prep. Next 5 ml of 62% Percoll (HBSS-prep) solution was added to a 15 ml 
tube and the bone marrow solution was slowly layered on percoll using a glass pipette. 
The new percoll bone marrow solution was centrifuged at 1000g for 30 min with the brake 
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turned off. Following centrifugation, neutrophils were removed from the solution by 
isolating the cloudy pellet at the top of the 62.5% percoll gradient and washed twice in 
HBSS-prep. Neutrophils were re-suspended and counted for use in appropriate assay.  
 
Transwell migration assay 
Transwell migration assays were performed using the QCM Chemotaxis Cell Migration 
Assay (EMD Millipore). Briefly, Human umbilical vein endothelial cells (HUVEC) were 
plated at a density of 2.5 x105 cells/250µl/well and allowed to adhere and rest for 48 hrs 
in the upper well. Following the resting period HUVECs were treated with 20ng/ml of 
TNFα for 18 hrs. After the 18 hr treatment period the upper well was gently placed into a 
lower well containing 250 ml of media containing 1µg/ml LPS and neutrophils were added 
to the upper well at a density of 5.0 x 105/250µl/well. Media from the lower wells were 
collected at set time points and analyzed for migration of neutrophils from the upper to 
lower well. 
 
2.3 Results 
 
Pressure ulcers generated in cPLA2α KI mice healing at an increased rate as 
compared to WT mice.  
Using a previously described pressure ulcer model (Stadler et al., 2004), pressure ulcers 
were generated in both cPLA2α KI and WT mice. Interestingly unlike the acute wound 
model previously discussed, differences in wound closure rate were able to be observed, 
in which starting at day 6 the cPLA2α KI mouse demonstrated a significant increase in 
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closure rate as compared to WT mice, which continued up until day 9 when on average 
both animals had demonstrated completely healed wounds. (Fig. 3.2A and B) These data 
lend to the hypothesis that the C1P/cPLA2α interaction plays a significant role in 
regulating wound closure in chronic wounds. 
 
Genetic ablation of the C1P/cPLA2α interaction increases neutrophil infiltration 
during the healing process.  
With the understanding that neutrophils are one of the major cell types regulating the 
inflammatory phase and more importantly for this study perpetuating chronic wound 
formation, we examined neutrophil infiltration rate after an ischemia reperfusion injury in 
dermal tissue. Wounds were generated using a modified version of the pressure ulcer 
model, in which only one ischemia/reperfusion cycle was performed. Wounds were then 
collected at set time points (0,2,4,8) and probed for neutrophil infiltration using the 
neutrophil marker Myeloperoxidase (MPO).(Kinkade et al., 1983) Unexpectedly, cPLA2α 
KI tissue samples demonstrated increased neutrophil infiltration as early as 2 hours post 
injury when compared to WT samples. (Fig. 3.3A). Using these data as a starting point 
,we employed a well-established in vitro trans-well migration assay (Benakanakere et al., 
2016) to examine the migration capabilities of neutrophils. As expected, neutrophils 
collected from cPLA2α KI mice migrated more rapidly than WT neutrophils (Fig. 3.3C) To 
this point the data demonstrate that in both an in vivo and in vitro model, neutrophils 
collected from cPLA2α KI mice infiltrate/migrate at a greater rate than WT neutrophils. 
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These data demonstrate that the rate of neutrophil infiltration may be playing a significant 
role in the regulation of chronic wounds.  
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Figure 3.1 Classification of the four stages of pressure ulcers. 
Pressure ulcers are injuries that can occur to skin and the underlying tissue that can range 
from mild redness of the skin to full tissue loss in the affected area. Due to the variance 
of the injury, healthcare professionals use a four-stage system to describe the severity of 
injury to the affect area. Stage 1 is the least severe and classified by having no open 
wounds, mild pain, and reddened skin that does not blanch after touch. Stage 2 ulcers 
are characterized by a painful open wound, which may extend into deeper layers of tissue. 
Most often these wounds appear as blisters, scrapes, and occasionally open craters. 
Stage 3 ulcers are classified by significant tissue loss the extends through all the dermal 
areas and begins to expose adipose tissue in the injured area. Lastly, stage 4 ulcers are 
full thickness wounds that contain severe tissue damage through all layers of tissue, 
generally with exposed bone, tendon, and muscle.  
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Figure 3.2 Genetic ablation of the C1P/cPLA2α interaction regulates wound 
closure in pressure ulcers. 
Closure rate of pressure ulcers in C57BL/6 WT and cPLA2α KI mice were observed using 
the previously described pressure ulcer model (Stadler et al., 2004). (A) Pressure ulcers 
of cPLA2α KI mice close at a significantly increased rate as compared to WT controls (B) 
Percent opened wound of C57/BLK6 WT and cPLA2α KI over course of 10 days. Samples 
were compared using an unpaired students t-test with Welch’s correction. Data shown 
are means + SD, n = 2-14 samples per group, n = 2-12 *P< 0.05, **P< 0.01, ***P< 0.001, 
****P< 0.0001. 
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Figure 3.3 cPLA2α KI Neutrophils infiltrate wounded tissue at a greater rate than 
WT Neutrophils.  
Using the previously described ischemia reperfusion model neutrophil infiltration into 
wounded tissue was observed at various time points (0,2,4,8) (A) Interestingly, 
neutrophils from cPLA2α KI mice appeared to infiltrate into wounded tissue at an 
increased rate beginning at hour 2, as compared to hour 4 for WT mice. (B) Transwell 
migration data demonstrated cPLA2 KI neutrophils migrated at a significantly increased 
rate as compared to both WT and cPLA2α KO neutrophils. Samples were compared using 
ANOVA followed by Tukey's post-hoc test. Data shown are means + SD, n = 2 samples 
per group, *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001. 
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3.4 Discussion 
 Though chronic wounds can occur in normally healthy individuals a significant 
population of individuals suffering with chronic wounds have primary illnesses that 
contributed to the formation and continuation of chronic wounds, such as diabetes and 
malnutrition. These primary conditions setup an environment allowing the wound 
environment to continually re-set and never progress past the inflammatory phase 
(Munro, 2017), which makes inflammatory response regulation an important topic of 
research in the wound healing field.  
 Using this knowledge and branching off from previous work in the Chalfant lab we 
explored the role of the C1P/cPLA2α interaction in a chronic wound model. We did this by 
utilizing our novel cPLA2 KI mouse model to perform preliminary experiments. These 
experiments demonstrated that: (1) Pressure ulcer injuries in cPLA2α KI mice had an 
increased wound closure rate; and (2) cPLA2α KI neutrophil infiltration and migration 
occur at a greater rate both in vivo and in vitro, as compared to WT neutrophils. We 
believe these novel phenotypes to be associated with the genetic ablation of the 
C1P/cPLA2α interaction. Interestingly, the generation of C1P from sphingomyelinase D 
(SMase D) (Lee & Lynch, 2005)  has been shown to be a potent regulator of chronic 
wound development, which affirms the hypothesis that continued association of cPLA2α 
with membrane C1P may be a key cellular mechanism linked to the “stalling” of the wound 
healing process in pressure ulcers.  
 In conclusion these preliminary experiments demonstrate that the C1P/cPLA2α 
interaction plays a pivotal role in chronic wounds and that by genetically ablating their 
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interaction we are able to increase the closure rate of pressure ulcers in a murine model, 
additionally, we demonstrated that neutrophils from cPLA2α KI mice infiltrated the wound 
site as early as 2 hours post wounding, while WT neutrophils took as long as 4 hours to 
infiltrate, and lastly we showed that the increase in infiltration rate associated with cPLA2α 
KI neutrophils can be tied to an increase in migration capabilities by using Transwell 
migration assays, which showed significantly more migrated neutrophils in cPLA2α KI 
samples. To that end, further mechanistic studies will be required to show and confirm 
what cell types and signaling molecules are playing a significant role in the observed 
phenotype. 
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CHAPTER FOUR 
DISCUSSION 
4.1 Significance  
One of the more important points of this study is the demonstration of a specific role for 
a defined lipid:protein interaction in vivo. To our knowledge, this is the first time that a 
validated lipid:protein interaction has been genetically ablated to discern specific 
mechanistic roles at the in vivo level. Whereas many lipid:protein interactions have been 
biophysically and cellularly defined (e.g., DAG/PKC interaction, PIP3/AKT), these studies 
were not extended to in vivo phenotypes. In the present study, we have bolstered a 
decade of enzymology, biophysical assays, and cellular analyses to show that the 
C1P/cPLA2α interaction is a major regulator of cPLA2α function, both positively to drive 
prostaglandin formation in vivo and negatively to regulate the formation of HETEs, via a 
previously unknown “shifting” mechanism. The findings open the door to examination of 
the temporal shift in cPLA2α function in cells in response to various inflammatory agonists 
in many physiologic contexts. For example, neutrophils and macrophages, depending on 
the timing and agonist, may shift their lipid profile to switch from inflammation to 
recruitment of more pro-resolution cell types. Furthermore, there is precedent to a shift 
between pro-inflammatory and pro-resolution phenotypes in many physiologies (e.g., 
sepsis) and cell types (e.g., macrophages) regulated by cPLA2α-derived lipids (e.g., 
lipoxins, resolvins). (Schwab & Serhan, 2006; Serhan, 2010; Serhan, Chiang, & Van 
Dyke, 2008) 
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4.2 Future directions 
 While great strides have been made in the understanding of the C1P/cPLA2, 
interaction further work is still required to fully elucidate all the roles cPLA2α is able to 
play. Future experiments confirming the hypothesis that by genetically ablating the 
C1P/cPLA2α interaction we are causing a shift in the function of cPLA2α to a more 
calcium-independent role generally associated with PIP2 regulation of the enzyme would 
be of particular interest. Additionally, further work examining how genetically ablating the 
C1P/cPLA2α is regulating wound closure in pressure ulcers would be exciting. A future 
experiment that can potentially answer the question of whether the inflammatory phase 
of wound healing is being compressed would involve looking at neutrophil infiltration 
during extended time points over the course of the healing process. This can be done 
multiple ways, with the ideal way involving crossing a previously described eGFP 
lysozyme mouse (Faust, Varas, Kelly, Heck, & Graf, 2000) with the cPLA2α KI and KO 
mice describe in the previous studies. Pressure ulcers can then be generated on the 
dorsum of mice and using a fluorescent imaging system neutrophil infiltration can be 
monitored in real time, which should reveal the time frame for both infiltration and exodus 
of neutrophils during the healing process in vivo. An additional experiment would be to 
look at inflammatory signaling molecules at various time points, specifically examining 
eicosanoid and cytokine levels during the early and late stages of wound closure. This 
can be accomplished by first generating pressure ulcers in WT, cPLA2α KI, and cPLA2α 
KO mice, followed by excision of the wound site at various time points, (0,3,5,7,10 days), 
at which point the wound can be split in two, one half for eicosanoid analysis and the 
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other half for cytokine analysis. Ideally this will give a deeper understanding of the 
signaling that is regulating the increased closure rate seen in cPLA2α KI mice.  
 
4.3 Concluding Remarks 
 To this point we have shown that genetic ablation of the C1P/cPLA2α interaction 
causes distinct changes in the infiltration of fibroblasts into the wound environment of 
acute wounds, we have also demonstrated that this increased level of infiltration is 
associated with wound maturation in the form of greater levels of type I collagen, 
decreases in the collagen rod diameter, and increases in the level of stress excisional 
wounds are able to tolerate. Next, we showed that specific lipid mediators, such as PGE2 
and 5-HETE are capable of regulating fibroblast migration and that the chemical inhibition 
of said mediators is able to abolish the migration phenotype. Additionally, we 
demonstrated that genetic ablation of the C1P/cPLA2α dramatically alters the localization 
of FLAP possibly explaining the increases in 5-HETE production. Lastly, preliminary data 
in this study shows that loss of the C1P/cPLA2α interaction increases the rate of wound 
closure in a murine pressure ulcer model, as well as increases neutrophil infiltration and 
migration both in vivo and in vitro. When examined as a whole, these data clearly indicate 
a significant role for the C1P/cPLA2α interaction in wound healing as well as provide a 
great understanding of the healing process and the singling mediators that are involved.  
 
 
 
 88 
 
List of References 
Ashcroft, G. S., Jeong, M.-J., Ashworth, J. J., Hardman, M., Jin, W., Moutsopoulos, N., 
… Wahl, S. M. (2012). Tumor necrosis factor-alpha (TNF-α) is a therapeutic target 
for impaired cutaneous wound healing. Wound Repair and Regeneration, 20(1), 
38–49. https://doi.org/10.1111/j.1524-475X.2011.00748.x 
Benakanakere, M. R., Finoti, L. S., Tanaka, U., Grant, G. R., Scarel-Caminaga, R. M., & 
Kinane, D. F. (2016). Investigation of the functional role of human Interleukin-8 
gene haplotypes by CRISPR/Cas9 mediated genome editing. Scientific Reports, 
6(1), 31180. https://doi.org/10.1038/srep31180 
Benusa, S. D., George, N. M., Sword, B. A., DeVries, G. H., & Dupree, J. L. (2017). 
Acute neuroinflammation induces AIS structural plasticity in a NOX2-dependent 
manner. Journal of Neuroinflammation, 14(1), 116. https://doi.org/10.1186/s12974-
017-0889-3 
Binoda, C., Portoukalian, J., Schmitt, D., Rodriguez-Lafrasse, C., & Ardail, D. (2004). 
Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-
associated membrane) and/or mitochondria? Biochemical Journal, 382(2), 527–
533. https://doi.org/10.1042/BJ20031819 
Blaho, V. A., Buczynski, M. W., Brown, C. R., & Dennis, E. A. (2009). Lipidomic 
Analysis of Dynamic Eicosanoid Responses during the Induction and Resolution of 
Lyme Arthritis. Journal of Biological Chemistry, 284(32), 21599–21612. 
https://doi.org/10.1074/jbc.M109.003822 
Borgeat, P., Hamberg, M., & Samuelsson, B. (1976). Transformation of arachidonic acid 
 89 
 
and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. 
Monohydroxy acids from novel lipoxygenases. The Journal of Biological Chemistry, 
251(24), 7816–7820. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/826538 
Bozza, P. T., Magalhães, K. G., & Weller, P. F. (2009). Leukocyte lipid bodies - 
Biogenesis and functions in inflammation. Biochimica et Biophysica Acta, 1791(6), 
540–551. https://doi.org/10.1016/j.bbalip.2009.01.005 
Brady, H. R., Persson, U., Ballermann, B. J., Brenner, B. M., & Serhan, C. N. (1990). 
Leukotrienes stimulate neutrophil adhesion to mesangial cells: modulation with 
lipoxins. American Journal of Physiology-Renal Physiology, 259(5), F809–F815. 
https://doi.org/10.1152/ajprenal.1990.259.5.F809 
Broughton, G., Janis, J. E., & Attinger, C. E. (2006). Wound healing: an overview. 
Plastic and Reconstructive Surgery, 117(7 Suppl), 1e-S–32e-S. 
https://doi.org/10.1097/01.prs.0000222562.60260.f9 
Chitturi, R. T., Balasubramaniam, A. M., Parameswar, R. A., Kesavan, G., Haris, K. T. 
M., & Mohideen, K. (2015). The role of myofibroblasts in wound healing, contraction 
and its clinical implications in cleft palate repair. Journal of International Oral 
Health : JIOH, 7(3), 75–80. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/25878485 
Cianci, E., Recchiuti, A., Trubiani, O., Diomede, F., Marchisio, M., Miscia, S., … 
Romano, M. (2016). Human Periodontal Stem Cells Release Specialized 
Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties 
Regulated by Lipoxins. STEM CELLS Translational Medicine, 5(1), 20–32. 
 90 
 
https://doi.org/10.5966/sctm.2015-0163 
Clark, J. D., Schievella, A. R., Nalefski, E. A., & Lin, L. L. (1995). Cytosolic 
phospholipase A2. Journal of Lipid Mediators and Cell Signalling, 12(2–3), 83–117. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8777586 
Clark, R. A. F. (1988). Wound Repair. In The Molecular and Cellular Biology of Wound 
Repair (pp. 3–50). Boston, MA: Springer US. https://doi.org/10.1007/978-1-4899-
0185-9_1 
Clark, R. A. F. (Richard A. F. ., & Henson, P. M. (Peter M. . (1988). The Molecular and 
cellular biology of wound repair. Springer Science+Business Media, LLC. 
Co., O. P. (2010). Opalmon -Oral prostaglandin E1 derivative preparation. 
Contaifer, D., Carl, D. E., Warncke, U. O., Martin, E. J., Mohammed, B. M., Van Tassell, 
B., … Wijesinghe, D. S. (2017). Unsupervised analysis of combined lipid and 
coagulation data reveals coagulopathy subtypes among dialysis patients. Journal of 
Lipid Research, 58(3), 586–599. https://doi.org/10.1194/jlr.P068833 
DeLigio, J. T., Lin, G., Chalfant, C. E., & Park, M. A. (2017). Splice variants of cytosolic 
polyadenylation element–binding protein 2 (CPEB2) differentially regulate pathways 
linked to cancer metastasis. Journal of Biological Chemistry, 292(43), 17909–
17918. https://doi.org/10.1074/jbc.M117.810127 
DeLozier, J. B., Reaves, L., King, L. E. J., & Rees, R. S. (1988). Brown recluse spider 
bites of the upper extremity. Southern Medical Journal, 81(2), 181–184. Retrieved 
from http://www.ncbi.nlm.nih.gov/pubmed/3340871 
 91 
 
Dhall, S., Wijesinghe, D. S., Karim, Z. A., Castro, A., Vemana, H. P., Khasawneh, F. T., 
… Martins-Green, M. (2015a). Arachidonic acid-derived signaling lipids and 
functions in impaired healing. Wound Repair and Regeneration : Official Publication 
of the Wound Healing Society [and] the European Tissue Repair Society, 23(5), 
644–656. https://doi.org/10.1111/wrr.12337 
Dhall, S., Wijesinghe, D. S., Karim, Z. a, Castro, A., Vemana, H. P., Khasawneh, F. T., 
… Martins-Green, M. (2015b). Arachidonic acid-derived signaling lipids and 
functions in impaired healing. Wound Repair and Regeneration : Official Publication 
of the Wound Healing Society [and] the European Tissue Repair Society, 23(5), 
644–656. https://doi.org/10.1111/wrr.12337 
Diegelmann, R. F., Evans, M. C., & others. (2004). Wound healing: an overview of 
acute, fibrotic and delayed healing. Front Biosci, 9(1), 283–9. 
Eming, S. A., Krieg, T., & Davidson, J. M. (2007). Inflammation in Wound Repair: 
Molecular and Cellular Mechanisms. Journal of Investigative Dermatology, 127(3), 
514–525. https://doi.org/10.1038/sj.jid.5700701 
Enoch, S., & Price, P. (2004). Pathophysiology-Of-Healing @ 
www.worldwidewounds.com. Retrieved from 
http://www.worldwidewounds.com/2004/august/Enoch/Pathophysiology-Of-
Healing.html 
Faust, N., Varas, F., Kelly, L. M., Heck, S., & Graf, T. (2000). Insertion of enhanced 
green fluorescent protein into the lysozyme gene creates mice with green 
fluorescent granulocytes and macrophages. Blood, 96(2), 719–726. 
 92 
 
Frykberg, R. G., & Banks, J. (2015). Challenges in the Treatment of Chronic Wounds. 
Advances in Wound Care, 4(9), 560–582. https://doi.org/10.1089/wound.2015.0635 
Galiano, R. D., Michaels, V. J., Dobryansky, M., Levine, J. P., & Gurtner, G. C. (2004). 
Quantitative and reproducible murine model of excisional wound healing. Wound 
Repair and Regeneration, 12(4), 485–492. https://doi.org/10.1111/j.1067-
1927.2004.12404.x 
Gillery, P., Fertin, C., Nicolas, J. F., Chastang, F., Kalis, B., Banchereau, J., & Maquart, 
F. X. (1992). Interleukin-4 stimulates collagen gene expression in human fibroblast 
monolayer cultures Potential role in fibrosis. FEBS Letters, 302(3), 231–234. 
https://doi.org/10.1016/0014-5793(92)80448-P 
Gonzalez, A. C. de O., Costa, T. F., Andrade, Z. de A., & Medrado, A. R. A. P. (2016). 
Wound healing - A literature review. Anais Brasileiros de Dermatologia, 91(5), 614–
620. https://doi.org/10.1590/abd1806-4841.20164741 
Greenhalgh, D. G. (1998). The role of apoptosis in wound healing. The International 
Journal of Biochemistry & Cell Biology, 30(9), 1019–1030. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/9785465 
GRILLO, H. C., WATTS, G. T., & GROSS, J. (1958). Studies in wound healing: I. 
Contraction and the wound contents. Annals of Surgery, 148(2), 145–160. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/13571889 
Hadanny, A., Fishlev, G., Bechor, Y., Meir, O., & Efrati, S. (2016). Nonhealing Wounds 
Caused by Brown Spider Bites. Advances in Skin & Wound Care, 29(12), 560–566. 
https://doi.org/10.1097/01.ASW.0000504578.06579.20 
 93 
 
Hankins, J. L., Ward, K. E., Linton, S. S., Barth, B. M., Stahelin, R. V, Fox, T. E., & 
Kester, M. (2013). Ceramide 1-phosphate mediates endothelial cell invasion via the 
annexin a2-p11 heterotetrameric protein complex. The Journal of Biological 
Chemistry, 288(27), 19726–19738. https://doi.org/10.1074/jbc.M113.481622 
Hawiger, J. (1987). Formation and regulation of platelet and fibrin hemostatic plug. 
Human Pathology, 18(2), 111–122. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/3804319 
Hoeferlin, L. A., Huynh, Q. K., Mietla, J. A., Sell, S. A., Tucker, J., Chalfant, C. E., & 
Wijesinghe, D. S. (2015). The Lipid Portion of Activated Platelet-Rich Plasma 
Significantly Contributes to Its Wound Healing Properties. Advances in Wound 
Care, 4(2), 100–109. https://doi.org/10.1089/wound.2014.0589 
Hoeferlin, L. A., Wijesinghe, D. S., & Chalfant, C. E. (2013). The Role of Ceramide-1-
Phosphate in Biological Functions. In Handbook of experimental pharmacology (pp. 
153–166). https://doi.org/10.1007/978-3-7091-1368-4_8 
Ireton, J. E., Unger, J. G., & Rohrich, R. J. (2013). The role of wound healing and its 
everyday application in plastic surgery: a practical perspective and systematic 
review. Plastic and Reconstructive Surgery. Global Open, 1(1). 
https://doi.org/10.1097/GOX.0b013e31828ff9f4 
Järbrink, K., Ni, G., Sönnergren, H., Schmidtchen, A., Pang, C., Bajpai, R., & Car, J. 
(2017). The humanistic and economic burden of chronic wounds: a protocol for a 
systematic review. Systematic Reviews, 6(1), 15. https://doi.org/10.1186/s13643-
016-0400-8 
 94 
 
Kennedy, D. F., & Cliff, W. J. (1979). A systematic study of wound contraction in 
mammalian skin. Pathology, 11(2), 207–222. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/460946 
Khorasani, H., Zheng, Z., Nguyen, C., Zara, J., Zhang, X., Wang, J., … Soo, C. (2011). 
A quantitative approach to scar analysis. The American Journal of Pathology, 
178(2), 621–628. https://doi.org/10.1016/j.ajpath.2010.10.019 
Kim, C., Liu, R., Kucia, M., & Ratajczak, M. Z. (2011). New Evidence That the Bioactive 
Lipid Ceramide-1-Phosphate (C1P) Is a Potent Chemoattractant for Mesenchymal 
Stromal Cells (MSC), Endothelial Progenitor Cells (EPCs) and Very Small 
Embryonic-Like Stem Cells (VSELs), Demonstrating Its Potential Involvemen…. 
Blood, 118(21). 
Kim, M.-H., Liu, W., Borjesson, D. L., Curry, F.-R. E., Miller, L. S., Cheung, A. L., … 
Simon, S. I. (2008). Dynamics of neutrophil infiltration during cutaneous wound 
healing and infection using fluorescence imaging. The Journal of Investigative 
Dermatology, 128(7), 1812–1820. https://doi.org/10.1038/sj.jid.5701223 
Kinkade, J. M., Pember, S. O., Barnes, K. C., Shapira, R., Spitznagel, J. K., & Martin, L. 
E. (1983). Differential distribution of distinct forms of myeloperoxidase in different 
azurophilic granule subpopulations from human neutrophils. Biochemical and 
Biophysical Research Communications, 114(1), 296–303. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/6192815 
Koh, T. J., & DiPietro, L. A. (2011). Inflammation and wound healing: the role of the 
macrophage. Expert Reviews in Molecular Medicine, 13(2008), e23. 
 95 
 
https://doi.org/10.1017/S1462399411001943 
Lamour, N. F., & Chalfant, C. E. (2008). Ceramide kinase and the ceramide-1-
phosphate/cPLA2alpha interaction as a therapeutic target. Current Drug Targets, 
9(8), 674–682. 
Lamour, N. F., Subramanian, P., Wijesinghe, D. S., Stahelin, R. V, Bonventre, J. V, & 
Chalfant, C. E. (2009). Ceramide 1-Phosphate Is Required for the Translocation of 
Group IVA Cytosolic Phospholipase A2 and Prostaglandin Synthesis. Journal of 
Biological Chemistry, 284(39), 26897–26907. 
https://doi.org/10.1074/jbc.M109.001677 
Lazarus, G. S., Cooper, D. M., Knighton, D. R., Margolis, D. J., Percoraro, R. E., 
Rodeheaver, G., & Robson, M. C. (1994). Definitions and guidelines for 
assessment of wounds and evaluation of healing. Wound Repair and 
Regeneration, 2(3), 165–170. https://doi.org/10.1046/j.1524-475X.1994.20305.x 
Lee, S., & Lynch, K. R. (2005). Brown recluse spider (Loxosceles reclusa) venom 
phospholipase D (PLD) generates lysophosphatidic acid (LPA). The Biochemical 
Journal, 391(Pt 2), 317–323. https://doi.org/10.1042/BJ20050043 
Lefer, A. M. (1985). Role of Thromboxane A2 in Coronary Vascular Disorders (pp. 309–
319). Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2589-5_26 
Leslie, C. C. (1997). Properties and regulation of cytosolic phospholipase A2. The 
Journal of Biological Chemistry, 272(27), 16709–16712. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/9201969 
 96 
 
Li, B., & Wang, J. H.-C. (2011). Fibroblasts and myofibroblasts in wound healing: Force 
generation and measurement. Journal of Tissue Viability, 20(4), 108–120. 
https://doi.org/10.1016/j.jtv.2009.11.004 
Lin, Z.-Q., Kondo, T., Ishida, Y., Takayasu, T., & Mukaida, N. (2003). Essential 
involvement of IL-6 in the skin wound-healing process as evidenced by delayed 
wound healing in IL-6-deficient mice. Journal of Leukocyte Biology, 73(6), 713–721. 
https://doi.org/10.1189/jlb.0802397 
Lorenz, H. P., & Longaker, M. T. (2008). Wounds: Biology, Pathology, and 
Management. In Surgery (pp. 191–208). New York, NY: Springer New York. 
https://doi.org/10.1007/978-0-387-68113-9_10 
Luo, L., Tanaka, R., Kanazawa, S., Lu, F., Hayashi, A., Yokomizo, T., & Mizuno, H. 
(2017). A synthetic leukotriene B4 receptor type 2 agonist accelerates the 
cutaneous wound healing process in diabetic rats by indirect stimulation of 
fibroblasts and direct stimulation of keratinocytes. Journal of Diabetes and Its 
Complications, 31(1), 13–20. https://doi.org/10.1016/j.jdiacomp.2016.09.002 
McFarland-Mancini, M. M., Funk, H. M., Paluch, A. M., Zhou, M., Giridhar, P. V., 
Mercer, C. A., … Drew, A. F. (2010). Differences in wound healing in mice with 
deficiency of IL-6 versus IL-6 receptor. Journal of Immunology (Baltimore, Md. : 
1950), 184(12), 7219–7228. https://doi.org/10.4049/jimmunol.0901929 
McGrath, M. H., & Simon, R. H. (1983). Wound geometry and the kinetics of wound 
contraction. Plastic and Reconstructive Surgery, 72(1), 66–73. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/6867179 
 97 
 
Midwood, K. S., Williams, L. V., & Schwarzbauer, J. E. (2004). Tissue repair and the 
dynamics of the extracellular matrix. The International Journal of Biochemistry & 
Cell Biology, 36(6), 1031–1037. https://doi.org/10.1016/J.BIOCEL.2003.12.003 
Mohammed, B. M., Fisher, B. J., Kraskauskas, D., Ward, S., Wayne, J. S., Brophy, D. 
F., … Natarajan, R. (2015). Vitamin C promotes wound healing through novel 
pleiotropic mechanisms. International Wound Journal, n/a-n/a. 
https://doi.org/10.1111/iwj.12484 
Morton, L. M., & Phillips, T. J. (2016). Wound healing and treating wounds: Differential 
diagnosis and evaluation of chronic wounds. Journal of the American Academy of 
Dermatology, 74(4), 589–605. https://doi.org/10.1016/J.JAAD.2015.08.068 
Moyon, S., Huynh, J. L., Dutta, D., Zhang, F., Ma, D., Yoo, S., … Casaccia, P. (2016). 
Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage. 
Cell Reports, 15(4), 748–760. https://doi.org/10.1016/J.CELREP.2016.03.060 
Munro, G. (2017). Causes and consideration with chronic wounds : a narrative review of 
the evidence. Wound Practice & Research: Journal of the Australian Wound 
Management Association, 25(2), 88–97. 
Niinikoski, J., Laato, M., Tschannen, R., & Fraefel, W. (1986). Effect of a 
hexosylceramide fraction of the hemodialysate Solcoseryl on wound-healing 
angiogenesis. The Journal of Surgical Research, 40(3), 261–264. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/2419669 
Nunan, R., Harding, K. G., & Martin, P. (2014). Clinical challenges of chronic wounds: 
searching for an optimal animal model to recapitulate their complexity. Disease 
 98 
 
Models & Mechanisms, 7(11), 1205–1213. https://doi.org/10.1242/dmm.016782 
Nussbaum, S. R., Carter, M. J., Fife, C. E., DaVanzo, J., Haught, R., Nusgart, M., & 
Cartwright, D. (2018). An Economic Evaluation of the Impact, Cost, and Medicare 
Policy Implications of Chronic Nonhealing Wounds. Value in Health : The Journal of 
the International Society for Pharmacoeconomics and Outcomes Research, 21(1), 
27–32. https://doi.org/10.1016/j.jval.2017.07.007 
Ordoñez, M., Rivera, I.-G., Presa, N., & Gomez-Muñoz, A. (2016). Implication of matrix 
metalloproteinases 2 and 9 in ceramide 1-phosphate-stimulated macrophage 
migration. Cellular Signalling, 28(8), 1066–1074. 
https://doi.org/10.1016/j.cellsig.2016.05.005 
Petreaca, M. L., Do, D., Dhall, S., McLelland, D., Serafino, A., Lyubovitsky, J., … 
Martins-Green, M. M. (2012). Deletion of a tumor necrosis superfamily gene in mice 
leads to impaired healing that mimics chronic wounds in humans. Wound Repair 
and Regeneration : Official Publication of the Wound Healing Society [and] the 
European Tissue Repair Society, 20(3), 353–366. https://doi.org/10.1111/j.1524-
475X.2012.00785.x 
Pettus, B. J., Bielawska, A., Spiegel, S., Roddy, P., Hannun, Y. a., & Chalfant, C. E. 
(2003). Ceramide kinase mediates cytokine- and calcium ionophore-induced 
arachidonic acid release. Journal of Biological Chemistry, 278(40), 38206–38213. 
https://doi.org/10.1074/jbc.M304816200 
Pickett, B. P., Burgess, L. P., Livermore, G. H., Tzikas, T. L., & Vossoughi, J. (1996). 
Wound healing. Tensile strength vs healing time for wounds closed under tension. 
 99 
 
Archives of Otolaryngology--Head & Neck Surgery, 122(5), 565–568. Retrieved 
from http://www.ncbi.nlm.nih.gov/pubmed/8615976 
Rådmark, O., Werz, O., Steinhilber, D., & Samuelsson, B. (2015). 5-Lipoxygenase, a 
key enzyme for leukotriene biosynthesis in health and disease. Biochimica et 
Biophysica Acta - Molecular and Cell Biology of Lipids, 1851(4), 331–339. 
https://doi.org/10.1016/j.bbalip.2014.08.012 
Rapala, K. (1996). The effect of tumor necrosis factor-alpha on wound healing. An 
experimental study. Annales Chirurgiae et Gynaecologiae. Supplementum, 211, 1–
53. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8790842 
RASCHE, H. (2001). Haemostasis and thrombosis: an overview. European Heart 
Journal Supplements, 3(suppl_Q), Q3–Q7. https://doi.org/10.1016/S1520-
765X(01)90034-3 
Rennekampff, H.-O., Hansbrough, J. F., Kiessig, V., Doré, C., Sticherling, M., & 
Schröder, J.-M. (2000). Bioactive Interleukin-8 Is Expressed in Wounds and 
Enhances Wound Healing. Journal of Surgical Research, 93(1), 41–54. 
https://doi.org/10.1006/jsre.2000.5892 
Romana-Souza, B., Santos, J. S. dos, Bandeira, L. G., & Monte-Alto-Costa, A. (2016). 
Selective inhibition of COX-2 improves cutaneous wound healing of pressure ulcers 
in mice through reduction of iNOS expression. Life Sciences, 153, 82–92. 
https://doi.org/10.1016/j.lfs.2016.04.017 
Rosenblum, J., & Papamichael, M. (2016). Combined Ultrasound and Electric Field 
Stimulation Aids the Healing of Chronic Pressure Ulcers. Journal of Gerontology & 
 100 
 
Geriatric Research, 5(4), 1–4. https://doi.org/10.4172/2167-7182.1000319 
Sandulache, V. C., Parekh, A., Li-Korotky, H.-S., Dohar, J. E., & Hebda, P. A. (2006). 
Prostaglandin E2 differentially modulates human fetal and adult dermal fibroblast 
migration and contraction: implication for wound healing. Wound Repair and 
Regeneration, 14(5), 633–643. https://doi.org/10.1111/j.1743-6109.2006.00156.x 
Schmidt, M. J., Tschoeke, A., Noronha, L., Moraes, R. S. de, Mesquita, R. A., Grégio, 
A. M. T., … Johann, A. C. B. R. (2016). Histochemical analysis of collagen fibers in 
giant cell fibroma and inflammatory fibrous hyperplasia. Acta Histochemica, 118(5), 
451–455. https://doi.org/10.1016/J.ACTHIS.2016.04.007 
Schwab, J. M., & Serhan, C. N. (2006). Lipoxins and new lipid mediators in the 
resolution of inflammation. Current Opinion in Pharmacology, 6(4), 414–420. 
https://doi.org/10.1016/j.coph.2006.02.006 
Seluanov, A., Vaidya, A., & Gorbunova, V. (2010). Establishing primary adult fibroblast 
cultures from rodents. Journal of Visualized Experiments : JoVE, (44). 
https://doi.org/10.3791/2033 
Serhan, C. N. (2010). Novel lipid mediators and resolution mechanisms in acute 
inflammation: to resolve or not? The American Journal of Pathology, 177(4), 1576–
1591. https://doi.org/10.2353/ajpath.2010.100322 
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008). Resolving inflammation: dual anti-
inflammatory and pro-resolution lipid mediators. Nature Reviews. Immunology, 
8(5), 349–361. https://doi.org/10.1038/nri2294 
 101 
 
Shapiro, B. A., Vu, N. T., Shultz, M. D., Shultz, J. C., Mietla, J. A., Gouda, M. M., … 
Chalfant, C. E. (2016). Melanoma Differentiation-associated Gene 7/IL-24 Exerts 
Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the 
SRC/PKCδ Signaling Axis. The Journal of Biological Chemistry, 291(41), 21669–
21681. https://doi.org/10.1074/jbc.M116.737569 
Shultz, J. C., Vu, N., Shultz, M. D., Mba, M.-U. U., Shapiro, B. A., & Chalfant, C. E. 
(2012). The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-
mRNA. Molecular Cancer Research : MCR, 10(5), 660–669. 
https://doi.org/10.1158/1541-7786.MCR-11-0363 
Simanshu, D. K., Kamlekar, R. K., Wijesinghe, D. S., Zou, X., Zhai, X., Mishra, S. K., … 
Patel, D. J. (2013). Non-vesicular trafficking by a ceramide-1-phosphate transfer 
protein regulates eicosanoids. Nature, 500(7463), 463–467. 
https://doi.org/10.1038/nature12332 
Sivamani, R. K. (2014a). Eicosanoids and Keratinocytes in Wound Healing. Advances 
in Wound Care, 3(7), 476–481. https://doi.org/10.1089/wound.2014.0523 
Sivamani, R. K. (2014b). Eicosanoids and Keratinocytes in Wound Healing. Advances 
in Wound Care, 3(7), 476–481. https://doi.org/10.1089/wound.2014.0523 
Skotland, T., Hessvik, N. P., Sandvig, K., & Llorente, A. (2018). Exosomal lipid 
composition and the role of ether lipids and phosphoinositides in exosome biology. 
Journal of Lipid Research, jlr.R084343. https://doi.org/10.1194/jlr.R084343 
Stadler, I., Zhang, R.-Y., Oskoui, P., Whittaker, M. S., & Lanzafame, R. J. (2004). 
Development of a simple, noninvasive, clinically relevant model of pressure ulcers 
 102 
 
in the mouse. Journal of Investigative Surgery : The Official Journal of the Academy 
of Surgical Research, 17(4), 221–227. https://doi.org/10.1080/08941930490472046 
Stahelin, R. V., Subramanian, P., Vora, M., Cho, W., & Chalfant, C. E. (2007a). 
Ceramide-1-phosphate Binds Group IVA Cytosolic Phospholipase a 2 via a Novel 
Site in the C2 Domain. Journal of Biological Chemistry, 282(28), 20467–20474. 
https://doi.org/10.1074/jbc.M701396200 
Stahelin, R. V., Subramanian, P., Vora, M., Cho, W., & Chalfant, C. E. (2007b). 
Ceramide-1-phosphate Binds Group IVA Cytosolic Phospholipase a 2 via a Novel 
Site in the C2 Domain. Journal of Biological Chemistry, 282(28), 20467–20474. 
https://doi.org/10.1074/jbc.M701396200 
Stephenson, D. J., Hoeferlin, L. A., & Chalfant, C. E. (2017). Lipidomics in translational 
research and the clinical significance of lipid-based biomarkers. Translational 
Research : The Journal of Laboratory and Clinical Medicine, 189, 13–29. 
https://doi.org/10.1016/j.trsl.2017.06.006 
Subramanian, P., Vora, M., Gentile, L. B., Stahelin, R. V, & Chalfant, C. E. (2007). 
Anionic lipids activate group IVA cytosolic phospholipase A2 via distinct and 
separate mechanisms. Journal of Lipid Research, 48(12), 2701–2708. 
https://doi.org/10.1194/jlr.M700356-JLR200 
Theilla, M., Schwartz, B., Cohen, J., Shapiro, H., Anbar, R., & Singer, P. (2012). Impact 
of a nutritional formula enriched in fish oil and micronutrients on pressure ulcers in 
critical care patients. American Journal of Critical Care : An Official Publication, 
American Association of Critical-Care Nurses, 21(4), e102-9. 
 103 
 
https://doi.org/10.4037/ajcc2012187 
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002). 
Myofibroblasts and mechano-regulation of connective tissue remodelling. Nature 
Reviews. Molecular Cell Biology, 3(5), 349–363. https://doi.org/10.1038/nrm809 
Versteeg, H. H., Heemskerk, J. W. M., Levi, M., & Reitsma, P. H. (2013). New 
Fundamentals in Hemostasis. Physiological Reviews, 93(1), 327–358. 
https://doi.org/10.1152/physrev.00016.2011 
Vu, N. T., Park, M. A., Shultz, J. C., Goehe, R. W., Hoeferlin, L. A., Shultz, M. D., … 
Chalfant, C. E. (2013). hnRNP U enhances caspase-9 splicing and is modulated by 
AKT-dependent phosphorylation of hnRNP L. The Journal of Biological Chemistry, 
288(12), 8575–8584. https://doi.org/10.1074/jbc.M112.443333 
Vu, N. T., Park, M. A., Shultz, M. D., Bulut, G. B., Ladd, A. C., & Chalfant, C. E. (2016). 
Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation  
of NF-kappaB and Lung Tumorigenesis. Cancer Research, 76(10), 2977–2989. 
https://doi.org/10.1158/0008-5472.CAN-15-2512 
Wallroth, A., & Haucke, V. (2018). Phosphoinositide conversion in endocytosis and the 
endolysosomal system. The Journal of Biological Chemistry, 293(5), 1526–1535. 
https://doi.org/10.1074/jbc.R117.000629 
Wang, X., Ge, J., Tredget, E. E., & Wu, Y. (2013a). The mouse excisional wound 
splinting model, including applications for stem cell transplantation. Nature 
Protocols, 8(2), 302–309. https://doi.org/10.1038/nprot.2013.002 
 104 
 
Wang, X., Ge, J., Tredget, E. E., & Wu, Y. (2013b). The mouse excisional wound 
splinting model, including applications for stem cell transplantation. Nature 
Protocols, 8(2), 302–309. https://doi.org/10.1038/nprot.2013.002 
Ward, K. E., Bhardwaj, N., Vora, M., Chalfant, C. E., Lu, H., & Stahelin, R. V. (2013). 
The molecular basis of ceramide-1-phosphate recognition by C2 domains. Journal 
of Lipid Research, 54(3), 636–648. https://doi.org/10.1194/jlr.M031088 
White, E. S., Atrasz, R. G., Dickie, E. G., Aronoff, D. M., Stambolic, V., Mak, T. W., … 
Peters-Golden, M. (2005a). Prostaglandin E(2) inhibits fibroblast migration by E-
prostanoid 2 receptor-mediated increase in PTEN activity. American Journal of 
Respiratory Cell and Molecular Biology, 32(2), 135–141. 
https://doi.org/10.1165/rcmb.2004-0126OC 
White, E. S., Atrasz, R. G., Dickie, E. G., Aronoff, D. M., Stambolic, V., Mak, T. W., … 
Peters-Golden, M. (2005b). Prostaglandin E2 Inhibits Fibroblast Migration by E-
Prostanoid 2 Receptor–Mediated Increase in PTEN Activity. American Journal of 
Respiratory Cell and Molecular Biology, 32(2), 135–141. 
https://doi.org/10.1165/rcmb.2004-0126OC 
Wijesinghe, D. S., Brentnall, M., Mietla, J. a., Hoeferlin, L. a., Diegelmann, R. F., Boise, 
L. H., & Chalfant, C. E. (2014). Ceramide kinase is required for a normal eicosanoid 
response and the subsequent orderly migration of fibroblasts. The Journal of Lipid 
Research, 55(7), 1298–1309. https://doi.org/10.1194/jlr.M048207 
Wilgus, T. A., Roy, S., & McDaniel, J. C. (2013). Neutrophils and Wound Repair: 
Positive Actions and Negative Reactions. Advances in Wound Care, 2(7), 379–388. 
 105 
 
https://doi.org/10.1089/wound.2012.0383 
Wong, V. W., Sorkin, M., Glotzbach, J. P., Longaker, M. T., & Gurtner, G. C. (2011a). 
Surgical approaches to create murine models of human wound healing. Journal of 
Biomedicine & Biotechnology, 2011, 969618. https://doi.org/10.1155/2011/969618 
Wong, V. W., Sorkin, M., Glotzbach, J. P., Longaker, M. T., & Gurtner, G. C. (2011b). 
Surgical Approaches to Create Murine Models of Human Wound Healing. Journal 
of Biomedicine and Biotechnology, 2011, 1–8. https://doi.org/10.1155/2011/969618 
Xue, M., & Jackson, C. J. (2015). Extracellular Matrix Reorganization During Wound 
Healing and Its Impact on Abnormal Scarring. Advances in Wound Care, 4(3), 119–
136. https://doi.org/10.1089/wound.2013.0485 
Yu, H., Yuan, L., Xu, M., Zhang, Z., & Duan, H. (2014). Sphingosine kinase 1 improves 
cutaneous wound healing in diabetic rats. Injury, 45(7), 1054–1058. 
https://doi.org/10.1016/j.injury.2014.03.003 
 
 
 
 
 
 
 
 106 
 
Vita 
 
In the 1988th year of our lord Henry Patrick Reece MacKnight was birthed at Parkland 
Hospital in the land of Dallas, Texas. He graduated from Mineral Heights Christian 
Academy, Greenville, Texas in 2007. Against all odds he received his Bachelor of 
Sciences in the field of Biological Sciences at Texas A&M University-Commerce in the 
Spring of 2013. In the Fall of 2013, Patrick begin his graduate studies at Virginia 
Commonwealth University and shortly thereafter joined the lab of Charles Chalfant in the 
Biochemistry Department. While in Dr. Chalfant’s laboratory, he began investigating the 
pivotal role that the C1P/cPLA2α interaction played in wound healing. Patrick completed 
his PhD Training under the guidance and direction of Charles Chalfant in the fall of 2018. 
 
